rfhg_152840.1

Basic information about the TSS

---

TSS ID: rfhg_152840.1 Species: human Chr: chr12		Start: 64404299 End: 64404305 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2569695,EH38E1619596)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000332707.10:87 GeneID: 11260 HGNC/MGI_ID: HGNC:12826 UniProt_ID: O43592 Nearer transcript ids and distances:

Gene_name: XPOT Gene_symbol: XPOT Gene_synonyms: XPO3 Gene_source: HGNC:12826

TATA-Box annotation

---

Distance to TSS:	-90
Nearest PromoterID:	NM_007235
Entrez ID:	11260
Nearest Unigene:	Hs.85951
Nearest Refseq:	NM_007235
Nearest Ensembl:	ENSG00000184575
Gene Name:	XPOT
Gene Alias:	XPO3
Gene Type:	protein-coding
CpG%:	0.333333
GC%:	0.857143
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@XPOT p2@XPOT p3@XPOT p4@XPOT p5@XPOT p6@XPOT p7@XPOT p8@XPOT
Sample		p1@XPOT	p2@XPOT	p3@XPOT	p4@XPOT	p5@XPOT	p6@XPOT	p7@XPOT	p8@XPOT
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.21	13.44	19.87	3.31	1.95	0.39	0.78	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.28	13.56	23.06	3.24	3.44	1.82	0.20	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.08	17.55	15.43	3.47	2.70	1.74	0.58	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	24.53	10.19	15.39	2.70	3.12	1.04	0.83	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.77	12.82	14.62	2.25	3.60	1.12	0.67	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.43	11.63	17.64	3.29	4.85	1.36	0.97	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	42.49	17.43	17.65	2.40	5.45	1.74	0.22	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	25.43	12.35	18.41	3.15	5.81	0.48	0.00	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.57	10.26	18.17	2.35	4.70	0.64	0.00	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	82.89	25.50	39.99	4.64	4.06	2.32	0.00	11.01
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	66.70	21.42	40.83	4.45	7.28	0.40	0.00	12.94
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	86.19	23.58	47.16	4.47	10.57	1.63	0.41	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.06	9.35	3.71	5.32	1.93	0.81	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.48	9.62	4.51	3.01	1.50	0.90	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.61	10.32	2.42	4.17	3.95	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.83	8.05	3.27	4.78	2.26	0.50	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.79	6.77	2.40	4.59	1.75	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.97	12.65	2.53	2.11	2.53	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.80	8.00	1.60	3.20	2.13	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.39	10.98	4.21	2.41	1.20	0.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.96	7.62	3.07	4.41	2.14	1.07	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.02	8.29	3.80	4.32	2.07	0.52	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.57	6.72	1.94	2.97	2.33	0.39	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	12.86	8.01	2.18	4.61	0.97	0.49	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.22	8.26	1.81	2.58	1.29	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.36	6.96	1.90	4.43	1.58	0.95	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	6.04	2.75	1.65	0.55	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	18.62	8.49	4.48	4.95	3.30	0.71	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.05	7.11	2.91	4.20	1.62	1.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.37	7.60	2.53	4.34	1.27	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.54	6.28	3.56	4.40	1.47	1.05	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.41	9.77	3.32	4.30	1.37	1.37	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.93	8.65	2.53	4.01	2.32	1.69	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	21.11	7.26	1.48	4.29	1.98	0.49	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.27	6.36	2.62	4.30	0.93	0.56	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.05	6.90	1.92	4.41	2.11	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.69	7.97	3.68	4.91	1.02	1.23	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	14.10	7.46	2.01	2.62	0.81	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.13	6.75	3.24	2.97	2.43	1.62	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	17.28	5.04	2.88	2.64	0.96	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.47	7.06	2.59	4.23	2.12	1.41	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	17.86	6.59	2.34	4.98	1.32	0.88	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.55	6.54	3.59	3.37	1.05	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	15.91	7.52	3.32	3.50	1.05	1.05	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.86	7.63	2.61	5.02	0.80	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.52	6.98	4.19	4.42	1.40	0.70	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	7.92	2.40	4.80	1.20	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.86	5.07	3.28	1.49	2.68	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.54	4.79	3.11	3.35	2.15	0.96	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.42	5.26	3.24	4.45	1.42	1.21	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.04	6.76	3.28	3.69	1.43	1.84	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.80	6.45	3.78	5.11	2.45	1.56	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	41.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	16.32	2.84	3.55	4.26	1.06	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.22	6.96	5.96	4.97	3.31	1.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	30.20	9.23	5.87	5.87	3.36	5.03	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	34.90	5.97	2.76	4.13	1.38	3.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.98	6.81	6.81	2.59	4.86	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	26.01	7.07	3.21	7.71	1.28	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	33.95	7.86	5.03	2.20	2.83	1.57	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.27	5.64	7.76	8.46	5.64	2.12	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.92	6.73	6.73	8.97	5.05	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	39.81	16.72	14.33	4.78	3.98	10.35	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.73	10.53	6.80	4.08	6.12	1.70	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	36.39	8.77	9.75	7.80	3.57	1.30	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.82	7.81	11.36	10.29	3.55	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	16.16	16.16	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	31.59	23.69	7.90	7.90	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.04	10.24	9.75	9.26	3.90	2.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.84	17.36	9.92	5.45	4.96	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.42	8.91	11.26	11.26	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	25.83	12.59	4.97	4.64	4.64	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.13	15.78	10.83	10.83	3.40	3.40	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.07	14.06	11.01	10.70	3.06	1.53	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	63.04	18.21	14.25	10.29	3.96	0.95	0.48	0.95
Adipocyte - breast, donor2	11327-117E4	24.22	16.04	11.87	9.47	2.41	3.05	0.16	0.96
Adipocyte - omental, donor1	11473-119C6	95.80	26.85	21.50	14.50	7.25	1.15	0.38	1.53
Adipocyte - omental, donor2	11474-119C7	20.93	8.97	8.97	3.74	3.74	2.24	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	21.43	16.08	13.40	7.03	3.68	1.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	35.73	19.78	6.38	5.74	5.10	1.91	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	3.30	4.40	4.40	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	10.84	8.58	3.16	2.71	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	4.00	6.26	5.73	3.82	0.35	0.52	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	31.10	25.03	13.10	8.02	3.72	0.78	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	17.50	10.04	6.69	9.01	1.80	1.03	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.55	16.17	18.40	13.94	4.46	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	29.39	17.63	6.47	10.58	1.18	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.00	18.90	11.90	7.64	1.37	0.32	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	14.20	12.91	5.49	9.68	1.94	1.29	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.26	8.00	5.87	3.73	3.73	2.13	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	12.24	11.69	5.01	1.67	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	13.31	9.98	4.57	3.74	1.66	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	7.28	7.79	8.04	6.53	1.00	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.53	7.85	7.20	4.58	0.33	0.98	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.92	5.78	6.39	6.70	0.61	0.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	7.73	3.31	5.08	1.99	0.44	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	0.72	0.72	0.00	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	3.59	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.65	3.60	3.60	6.66	1.08	0.18	0.72	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	1.67	5.02	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.22	2.47	3.08	1.03	0.41	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	7.09	5.26	2.75	4.46	0.34	0.11	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	6.86	3.92	2.20	2.69	0.24	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	1.80	1.35	2.70	0.00	2.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	4.78	3.04	4.78	1.30	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	4.28	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.78	2.09	3.29	2.99	2.39	0.60	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	3.79	0.00	2.53	1.26	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	5.28	1.98	3.96	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.17	1.95	5.52	3.90	1.62	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	4.85	2.91	5.83	2.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	1.19	0.00	2.97	0.59	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.40	2.26	4.14	1.51	1.51	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	5.08	3.63	2.90	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	3.76	1.25	2.51	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.32	6.10	4.28	3.95	1.48	0.00	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	2.73	1.36	6.82	2.73	2.73	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.17	5.58	5.88	4.37	1.51	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	5.89	2.14	2.68	2.14	1.61	1.61	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.90	3.59	2.83	3.97	1.32	0.00	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.56	4.01	1.60	2.67	1.87	0.53	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	5.85	6.83	0.98	1.95	2.93	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.62	6.14	4.64	3.32	1.99	0.66	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	2.40	3.60	4.80	2.40	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	7.08	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.12	6.35	6.00	3.77	1.37	0.34	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.31	3.40	5.83	3.40	0.00	1.94	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.32	4.17	3.79	4.93	1.90	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	4.85	1.21	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	3.42	0.57	1.71	1.71	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.83	4.92	4.06	4.06	1.50	0.43	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.26	5.94	2.84	2.84	1.29	0.52	1.03	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.38	3.75	2.82	2.82	2.82	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.68	3.54	3.54	3.22	1.93	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	3.57	1.43	3.57	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	2.92	4.68	2.92	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.53	6.02	3.61	4.52	1.81	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	2.38	4.75	2.38	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	3.05	3.56	1.53	1.02	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.91	3.82	3.57	3.82	1.78	1.78	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	5.72	4.45	0.00	2.54	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	2.16	4.32	2.59	2.59	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.16	3.39	3.60	5.29	1.69	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.12	1.45	2.90	3.77	0.87	0.00	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	3.78	1.89	5.67	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.34	5.26	2.88	3.22	1.02	0.51	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	4.63	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	6.34	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.86	3.65	4.29	3.00	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	1.80	1.80	5.41	1.80	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	4.37	2.19	3.64	0.73	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.51	5.98	6.44	2.76	0.46	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	0.00	2.55	2.55	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.68	5.08	4.83	9.15	1.02	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.59	4.95	3.92	4.13	1.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	4.90	4.28	3.37	1.22	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	3.35	3.35	3.35	2.39	1.43	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.64	3.55	3.99	3.55	1.77	0.22	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	0.00	1.53	4.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	3.88	1.66	1.66	1.66	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.33	3.18	4.77	5.56	0.53	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.72	3.27	3.27	1.09	1.82	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	6.51	3.68	1.23	1.97	1.23	0.00	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	6.68	2.23	1.54	0.86	0.68	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.08	3.99	1.89	0.21	1.47	0.42	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	19.17	11.50	4.53	4.88	3.14	0.00	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	26.69	12.78	4.53	5.82	5.18	0.65	0.49	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	23.42	18.05	6.56	3.13	2.68	1.19	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	12.39	25.00	11.01	7.11	1.61	0.92	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	13.03	23.43	11.78	7.77	1.88	0.88	0.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.83	26.40	9.33	8.08	1.02	0.34	0.00	0.23
Basophils, donor1	12241-129G9	4.45	2.88	2.62	1.05	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	11.55	9.38	5.05	4.33	1.08	0.72	0.00	0.00
Basophils, donor3	12243-129H2	2.94	7.64	2.65	3.23	0.59	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	3.88	3.02	2.59	1.51	0.65	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	0.00	0.46	0.91	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	21.52	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	6.28	4.39	1.88	0.63	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.19	5.41	3.54	1.87	0.83	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	12.21	19.34	10.82	6.22	3.68	0.92	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	7.38	11.52	5.40	5.58	1.08	1.26	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	46.68	44.31	30.09	21.23	2.89	0.52	0.52	1.75
Burkitt's lymphoma cell line:RAJI	10476-106I8	35.17	49.14	49.61	35.17	3.03	2.56	1.63	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	42.21	14.39	7.99	5.76	2.24	0.32	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.38	6.20	1.69	1.13	0.00	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	2.23	7.05	2.23	1.11	1.30	0.37	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	4.17	6.59	1.76	1.76	0.22	0.66	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3.40	12.17	3.68	6.79	1.13	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.20	6.82	6.82	5.31	0.76	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.92	13.48	3.94	6.90	0.33	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	13.59	4.19	2.17	1.16	0.58	0.72	0.14	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	16.90	5.13	3.62	3.32	0.30	0.91	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	20.37	4.03	3.79	0.47	0.71	0.47	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.19	1.84	0.84	1.00	0.67	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.70	3.59	1.38	1.66	0.55	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	13.64	4.71	2.98	1.24	1.24	0.00	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.35	2.74	1.96	0.98	0.98	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.37	1.60	1.42	0.71	0.89	0.53	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.18	2.18	1.31	1.31	0.65	0.44	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.40	2.11	0.94	0.47	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	4.75	3.70	1.06	1.06	0.53	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	4.44	0.00	1.11	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.78	2.83	1.04	0.45	0.59	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.17	3.99	2.00	1.00	1.40	0.60	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.99	3.96	2.50	0.62	0.83	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.38	1.83	1.83	0.69	0.69	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	13.80	4.07	2.49	0.90	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	2.62	1.75	1.31	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.84	2.96	0.27	0.00	0.27	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.34	4.01	1.05	1.40	1.05	0.70	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.42	4.63	2.95	0.42	0.84	0.84	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.63	3.12	1.84	0.37	0.73	0.55	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.73	9.86	3.17	1.06	1.41	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	18.87	4.83	2.63	0.88	1.32	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.01	1.22	0.52	0.52	0.17	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	6.32	2.97	1.12	1.49	0.74	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.04	3.02	0.65	1.08	0.43	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.09	2.05	0.41	0.41	0.00	1.23	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.52	5.33	2.55	1.85	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	10.21	3.94	1.39	0.93	0.46	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	1.74	4.14	2.40	2.40	0.65	0.65	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	1.62	5.08	1.62	2.77	0.23	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	1.08	5.20	3.03	2.38	0.22	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	5.61	8.72	3.43	2.49	1.56	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	2.79	7.86	2.62	2.27	0.87	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	5.13	8.70	6.02	2.68	0.45	0.45	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	2.04	3.06	3.06	2.55	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.54	3.51	2.85	2.63	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.84	5.47	2.74	3.16	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	8.13	10.16	4.06	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	8.14	5.42	4.75	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	9.32	3.11	6.21	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.00	11.73	2.67	4.80	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	9.11	3.22	8.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	8.42	6.32	0.70	6.32	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	10.98	3.14	3.14	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5.27	13.18	3.95	6.59	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	10.68	9.04	4.11	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	2.90	4.35	5.08	3.63	0.73	1.45	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	2.02	8.58	3.03	2.52	0.00	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	19.80	35.56	20.61	5.25	1.21	1.62	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.38	25.17	17.18	3.99	1.20	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	3.01	0.00	1.00	1.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.84	8.99	1.12	0.56	0.56	0.00	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.44	19.92	7.52	10.52	3.38	1.50	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.87	23.45	8.57	6.31	3.38	0.90	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	8.93	19.64	8.93	9.28	1.43	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	7.35	23.88	7.35	4.29	0.00	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	7.93	20.13	6.40	7.93	1.22	0.91	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.04	14.55	10.21	4.08	2.04	0.77	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	18.42	25.15	10.11	6.06	1.57	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	14.66	15.52	9.20	7.47	1.15	0.86	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.11	9.48	4.74	1.42	1.42	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	3.51	11.24	8.43	6.32	0.00	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	23.07	3.30	6.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	13.44	9.54	8.53	4.77	1.73	0.58	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	18.30	12.37	12.37	9.83	1.36	1.02	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	14.19	12.57	10.48	5.16	1.61	0.64	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.69	8.07	4.48	3.59	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.29	12.93	9.08	4.19	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	10.56	10.12	8.36	4.84	0.88	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.49	11.38	10.54	2.53	1.26	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.67	12.05	7.90	6.86	1.66	0.83	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	10.36	13.37	3.34	3.01	0.67	0.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	3.54	18.76	7.61	4.35	0.54	0.82	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.22	15.01	8.04	3.75	1.61	1.07	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	12.55	5.38	5.38	5.38	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	18.73	17.43	9.46	6.12	2.23	0.37	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	17.11	16.03	8.01	3.25	2.17	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	13.45	13.03	8.83	4.62	0.63	0.42	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	9.10	14.66	5.56	2.53	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.53	9.96	3.90	4.77	0.87	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.46	16.56	6.54	4.36	0.87	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.35	20.29	7.42	6.43	1.98	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	13.85	12.00	7.39	7.39	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	13.96	4.19	2.79	1.40	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.95	20.49	7.20	3.05	1.11	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	17.18	20.12	8.10	5.89	0.98	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9.24	21.56	10.78	3.08	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.83	12.89	6.09	6.80	2.15	1.07	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11.08	20.77	4.15	2.77	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	16.04	13.42	8.18	7.20	0.98	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	17.27	7.88	4.88	2.63	1.13	1.13	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	9.34	17.67	9.85	4.04	0.76	0.25	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.32	11.70	6.65	8.26	0.92	0.23	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.14	9.35	7.67	5.75	2.88	1.20	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.53	10.40	10.12	4.92	1.64	1.92	1.09	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.11	12.91	5.10	4.80	0.60	1.20	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	16.08	9.60	7.44	5.52	2.16	1.92	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.87	7.73	6.82	8.64	1.36	0.00	1.14	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.99	11.95	7.17	5.87	2.39	1.09	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.26	10.26	8.95	3.16	2.90	0.53	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.77	10.55	11.73	5.86	2.81	0.70	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.74	14.19	8.15	4.53	3.02	1.21	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.60	14.53	8.72	4.65	3.49	1.74	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.98	15.72	8.26	3.46	2.93	0.80	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.39	16.63	12.26	4.38	1.31	0.88	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.32	17.76	10.93	5.47	1.82	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	6.71	12.68	4.48	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.05	11.52	9.36	6.48	1.08	1.08	1.80	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.93	8.06	6.91	6.04	2.88	1.15	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.50	10.61	5.66	4.24	1.89	0.24	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.11	15.85	9.19	7.61	3.80	1.27	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	18.15	12.61	11.07	5.23	2.77	1.23	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.71	13.79	9.30	3.85	3.85	0.32	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.16	20.27	12.24	4.59	6.12	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.59	18.52	10.25	7.09	3.55	2.36	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.21	15.13	14.37	7.56	1.51	1.51	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	21.68	36.94	24.89	14.45	4.01	6.42	0.80	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.08	47.56	34.97	13.99	5.60	3.50	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	50.09	31.05	9.02	9.02	0.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	10.97	1.83	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	6.92	5.43	1.98	1.48	0.99	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	36.09	19.26	17.47	12.84	2.84	0.42	0.32	0.32
Chondrocyte - de diff, donor1	11261-116G1	48.53	18.37	13.17	9.71	5.20	0.69	0.00	1.04
Chondrocyte - de diff, donor2	11338-117F6	27.36	12.79	8.17	10.66	1.78	0.71	1.42	0.00
Chondrocyte - de diff, donor3	11410-118E6	39.25	22.64	6.83	8.08	4.89	2.84	0.46	0.80
Chondrocyte - re diff, donor2	11339-117F7	101.16	17.91	8.06	6.27	5.37	0.00	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	38.42	17.39	7.28	8.09	4.04	0.81	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	39.48	11.13	5.85	4.02	2.52	0.11	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	23.73	8.76	4.49	3.42	1.28	1.28	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	24.07	12.39	3.63	3.72	2.21	1.24	0.00	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	5.14	13.94	5.23	8.99	1.56	0.28	0.18	0.28
Corneal Epithelial Cells, donor1	11526-119I5	3.29	5.27	1.32	2.42	0.22	0.44	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	4.55	2.28	1.14	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.14	3.58	3.83	3.07	0.51	0.51	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.44	10.73	3.30	1.98	0.66	0.17	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.05	7.89	2.84	2.52	0.95	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	10.35	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.67	9.50	2.16	1.62	1.40	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4.10	10.59	1.02	1.71	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.26	7.83	5.88	2.61	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.87	7.26	3.39	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	27.68	6.67	4.67	2.50	3.50	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	4.69	4.11	2.93	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.29	5.37	5.37	2.83	0.85	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	24.38	7.08	4.33	2.75	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.82	3.20	4.65	1.75	1.45	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	27.76	7.76	6.59	2.82	1.88	1.18	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	17.18	9.12	4.56	2.98	1.23	0.70	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.18	4.88	4.43	3.10	1.77	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.73	6.09	4.26	4.87	0.91	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.66	10.99	8.74	4.51	1.13	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	6.83	1.49	1.19	0.89	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	16.14	3.64	3.64	3.12	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	3.83	2.27	1.84	1.56	0.43	0.85	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	28.81	7.60	6.40	1.60	5.60	0.80	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	2.10	2.10	1.57	1.57	0.00	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.44	14.41	12.05	6.83	1.62	0.37	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	27.59	9.56	6.74	5.21	1.30	0.22	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	35.54	11.36	9.16	5.25	1.95	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	21.61	2.28	4.55	1.14	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	2.10	8.38	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	21.98	5.02	2.83	2.04	1.10	0.63	0.00	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	9.90	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.71	3.18	2.44	1.47	0.98	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	2.08	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	72.66	21.76	13.96	19.70	5.75	0.41	2.46	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.61	5.47	6.79	6.24	2.41	1.42	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.93	19.72	15.60	18.63	3.47	4.77	1.41	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	64.04	16.25	11.52	7.64	2.55	0.49	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	71.37	16.10	15.83	8.46	4.91	0.41	0.82	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	41.24	20.36	13.39	11.07	4.22	2.43	0.84	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.07	10.28	9.49	10.54	6.85	1.05	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.51	15.61	10.96	12.96	3.99	1.33	1.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	26.31	12.25	10.89	5.90	2.27	0.91	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	18.19	10.61	5.31	9.10	3.03	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	19.87	8.04	7.10	6.31	1.58	0.63	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	28.80	18.49	7.58	8.79	2.73	0.00	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	44.04	19.67	15.74	7.36	5.33	2.16	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	25.32	7.43	5.61	5.76	2.12	0.61	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.57	7.91	7.77	4.02	1.47	0.27	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	27.18	8.63	7.77	4.31	1.73	1.29	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	14.65	10.25	2.93	2.93	5.86	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	18.22	15.22	18.68	7.38	0.69	0.00	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	29.85	18.83	10.18	6.11	2.71	0.51	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	14.56	11.50	7.98	6.10	2.82	0.94	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	17.92	6.13	8.02	5.19	1.42	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	31.79	12.45	6.41	5.92	2.66	1.33	0.36	0.12
Fibroblast - Dermal, donor4	11450-119A1	49.63	20.69	13.90	8.70	9.04	1.70	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	58.79	18.84	18.14	7.68	5.93	1.92	1.22	0.17
Fibroblast - Dermal, donor6	11458-119A9	43.53	18.19	14.13	6.50	6.82	0.49	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	33.94	21.86	9.79	9.58	4.37	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	78.08	31.18	19.65	16.51	5.76	0.52	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	25.96	13.57	9.09	10.15	2.64	1.58	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	38.00	49.21	28.62	21.17	6.19	0.87	0.58	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	34.28	19.74	13.51	13.51	3.12	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	43.35	27.66	23.79	22.91	5.81	2.82	1.76	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.92	11.69	6.24	5.46	3.90	0.16	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.64	8.25	4.46	4.19	2.70	0.95	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.35	4.23	3.53	3.88	3.88	0.00	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	40.36	11.55	3.95	4.39	3.22	0.88	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.00	10.77	4.23	4.50	3.00	0.55	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	72.29	15.25	11.85	8.99	6.47	0.55	1.32	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	67.35	36.10	23.77	22.01	7.19	2.05	1.61	0.15
Fibroblast - Lung, donor1	11270-116H1	4.08	2.72	4.08	1.36	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	14.92	10.45	5.97	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.25	10.34	5.28	2.32	1.90	0.63	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	8.33	3.33	5.83	1.67	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	9.79	4.20	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	2.80	1.40	0.56	0.28	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	22.33	21.11	13.80	14.61	4.47	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	11.91	0.00	11.91	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	28.71	19.01	16.29	8.15	5.43	0.00	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	38.22	24.27	17.60	11.22	5.46	1.97	0.30	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	47.43	22.03	15.91	11.93	5.51	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	44.65	10.30	11.45	4.58	2.29	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.90	17.28	9.45	4.05	4.32	1.08	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	41.05	25.98	23.54	15.89	4.18	0.81	1.16	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	27.63	12.38	9.95	7.18	2.98	0.66	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.74	5.08	5.49	6.71	1.42	0.00	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	4.68	5.35	2.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	26.09	13.84	8.70	5.54	2.77	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	46.64	4.76	5.16	4.76	6.35	1.19	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	38.54	24.51	21.14	15.45	4.80	1.07	0.89	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.59	24.83	18.92	14.78	4.93	0.59	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	50.54	8.42	5.11	1.50	6.02	0.60	0.00	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	47.93	18.14	11.55	8.42	7.66	1.08	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	74.66	11.89	7.59	5.31	6.07	1.52	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	55.95	21.82	17.56	12.47	5.58	1.48	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	105.87	12.23	4.41	4.61	5.61	0.80	0.20	1.80
Fibroblast - skin normal, donor2	11561-120D4	88.61	15.27	9.04	8.84	6.23	0.70	0.50	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	61.96	10.88	6.04	3.93	6.65	0.91	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	76.30	32.89	22.37	17.56	8.04	1.33	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	48.38	25.30	14.70	13.68	6.50	1.54	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	36.46	5.25	4.27	2.63	6.24	0.99	0.00	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	47.40	11.08	5.43	8.31	3.73	0.32	0.11	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	28.17	7.59	4.55	3.04	2.53	1.01	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	52.53	20.86	12.23	10.19	4.70	5.18	0.47	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	66.48	0.00	44.32	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	5.23	2.61	6.97	1.74	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.72	7.97	6.76	3.29	1.04	0.17	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.92	11.19	4.16	10.41	2.08	0.52	1.82	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.54	9.71	3.83	4.85	0.77	0.00	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	20.67	13.78	7.66	0.77	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	21.69	21.06	5.10	3.19	3.83	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	18.54	64.18	33.66	18.26	2.85	2.00	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.99	29.23	9.65	3.58	1.65	0.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	22.15	29.23	10.05	7.53	1.14	1.14	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	17.44	47.95	25.56	15.65	2.58	0.20	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.80	31.46	5.02	2.91	2.64	0.53	0.00	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	29.68	25.77	10.11	8.15	1.96	0.98	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.48	54.84	37.15	11.50	1.77	1.77	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.62	34.62	16.25	7.77	1.41	1.41	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	7.02	30.54	13.79	9.11	2.34	1.23	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	18.00	43.25	16.65	10.75	2.95	0.81	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	10.04	20.44	9.66	5.20	3.35	0.87	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7.61	21.04	15.37	6.92	3.18	1.38	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	22.77	31.11	17.08	8.34	4.47	0.61	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.38	17.57	9.58	5.93	2.28	0.00	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	8.10	17.07	8.72	7.72	2.49	1.25	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	23.39	32.35	15.74	9.84	4.81	1.31	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.30	17.43	9.75	4.73	1.18	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	7.47	13.67	8.11	4.93	1.43	1.59	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.30	30.16	16.53	7.37	2.46	1.34	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.69	17.74	9.07	3.63	1.01	0.60	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	8.82	18.49	7.80	4.92	1.02	1.02	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.75	25.98	18.89	8.25	2.93	0.00	0.35	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.79	21.75	10.93	4.58	1.77	0.52	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.81	18.61	11.44	3.93	2.05	0.17	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.09	19.03	8.85	3.21	1.44	0.66	0.11	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.72	19.55	13.39	6.57	2.50	0.08	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.66	20.42	12.25	4.90	1.84	0.20	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.70	15.27	7.43	4.13	1.44	0.21	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.42	14.99	7.15	3.92	0.92	0.58	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.34	22.18	11.01	5.84	2.17	1.00	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	10.14	16.97	6.39	4.41	0.66	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	6.64	16.73	10.58	5.04	1.23	0.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	16.53	25.12	12.64	6.16	1.62	0.81	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	20.53	8.34	5.13	1.60	1.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.12	12.60	5.59	3.41	1.04	0.57	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.82	16.45	8.54	4.59	1.42	0.63	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	8.82	10.95	6.39	4.26	1.22	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	5.85	11.92	6.27	4.39	1.25	0.52	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.32	13.83	7.46	5.71	0.44	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	10.38	15.15	6.73	6.73	1.12	0.00	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5.83	7.87	5.09	3.89	1.48	0.37	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.51	13.64	7.22	2.41	2.67	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.75	12.09	6.43	3.52	2.45	0.61	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.16	7.64	7.38	2.72	1.55	0.39	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.08	13.28	9.49	4.34	1.90	0.54	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.75	13.09	7.74	5.53	1.66	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.50	12.94	6.36	4.39	2.63	0.88	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	10.91	9.92	5.95	2.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.82	12.66	5.14	5.54	2.24	0.53	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.54	10.89	8.47	3.03	2.62	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.52	30.25	11.44	9.40	1.78	0.00	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.52	51.36	20.70	8.76	3.58	0.60	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	7.09	49.61	18.34	8.17	3.24	1.69	0.15	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	10.84	45.83	18.62	9.21	1.23	1.02	0.61	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	31.92	15.02	6.26	2.50	1.88	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.39	31.93	15.82	7.35	1.70	1.13	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.37	38.74	14.30	7.38	0.46	3.69	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	44.55	22.27	12.37	2.47	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.47	22.82	15.47	7.35	0.77	3.87	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	28.88	14.44	6.42	0.00	4.81	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	38.25	12.17	6.96	0.00	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.30	24.09	16.92	7.16	1.63	2.28	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.94	23.06	12.35	4.12	2.47	3.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	16.66	23.33	3.33	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.22	25.45	9.51	4.19	1.68	1.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	19.28	20.26	17.32	6.54	2.61	2.29	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	8.39	29.36	5.87	7.55	2.52	6.71	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	14.00	24.81	11.77	5.73	1.91	1.59	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.57	21.06	8.49	3.74	3.06	2.04	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	12.53	22.97	4.18	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.03	26.34	10.88	4.58	2.29	1.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.62	13.62	6.81	3.55	2.07	0.89	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	15.25	15.25	3.39	1.69	5.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.91	19.05	8.28	7.04	2.90	2.49	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.74	18.64	8.74	3.91	2.30	1.38	0.23	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	10.76	4.23	5.77	0.38	1.54	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	6.19	10.43	8.48	5.22	2.61	1.63	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	12.04	16.72	6.02	6.02	1.34	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	10.02	20.42	6.55	5.01	0.77	1.93	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	25.68	20.88	13.69	3.42	4.11	1.37	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	29.82	29.82	9.94	2.48	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.49	26.90	8.02	5.19	0.94	2.83	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.28	19.31	7.85	5.43	0.60	4.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	9.16	26.96	13.23	6.61	1.53	1.53	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	9.17	14.76	9.17	5.58	2.39	2.79	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.83	26.64	11.35	5.43	2.96	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	21.25	24.79	3.54	3.54	5.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	5.25	15.75	8.17	4.08	1.17	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.80	24.58	19.75	5.71	2.19	2.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	10.17	17.80	11.02	0.85	0.00	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	4.78	14.33	9.55	6.57	0.60	2.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	6.79	11.16	5.82	3.40	1.46	1.46	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	6.85	4.57	2.28	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.80	6.65	4.16	2.91	2.08	1.66	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	12.37	1.12	3.37	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	3.81	2.85	2.54	0.63	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.35	4.60	1.25	6.27	2.51	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.66	10.33	6.73	3.13	2.32	1.51	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.58	12.49	6.92	3.88	2.70	1.18	0.00	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	19.34	10.01	6.83	3.41	2.28	0.91	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.46	11.04	7.11	2.84	2.08	0.98	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	22.78	10.32	8.17	3.22	3.01	1.29	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.65	9.26	6.89	4.31	2.15	0.86	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.68	8.34	6.23	3.74	1.49	1.12	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.87	8.75	6.52	1.89	1.89	1.37	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.66	10.89	7.37	4.49	2.88	0.96	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	5.60	2.24	2.24	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.63	3.03	1.73	1.73	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	4.94	2.47	1.76	1.41	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	2.18	1.45	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	21.16	10.84	9.44	6.82	1.40	0.87	0.00	0.00
Hepatocyte, donor1	11523-119I2	7.26	10.90	8.47	1.21	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	14.01	23.70	31.24	5.39	0.00	5.39	1.08	0.00
Hepatocyte, donor3	11684-122I1	9.20	22.09	20.25	15.34	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.11	31.98	26.11	5.22	0.65	2.61	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.09	27.97	13.63	6.99	2.45	1.57	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.82	9.47	6.45	3.16	1.37	0.14	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	9.55	6.37	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	20.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	11.08	8.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	7.51	5.01	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	17.94	2.56	7.69	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	0.00	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	17.87	6.50	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	11.67	8.34	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	7.26	10.89	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	13.23	9.26	5.29	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	12.20	6.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	15.71	5.24	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	11.97	9.45	1.26	1.26	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	7.73	4.64	6.19	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	43.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.88	10.98	5.81	2.58	2.58	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	3.22	9.66	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	35.84	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	13.04	9.78	2.44	1.63	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.27	8.40	5.04	0.84	1.68	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	14.37	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	8.04	8.84	1.61	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	9.23	6.46	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	15.08	15.08	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.83	4.72	3.78	2.36	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	4.53	2.72	0.00	1.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	7.53	6.46	3.23	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	7.62	3.81	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.19	8.93	5.74	3.19	0.64	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	14.58	0.00	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	7.14	5.00	2.14	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2.78	5.56	4.32	1.23	0.62	0.93	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	14.05	5.27	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	9.43	3.14	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.26	11.82	6.26	1.39	2.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	22.13	22.13	6.64	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	22.69	9.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	18.31	12.21	6.10	2.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	29.25	9.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	10.45	17.42	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	12.80	3.20	4.27	3.20	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	22.17	11.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	11.40	17.10	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	18.41	9.20	3.68	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	21.18	21.18	6.05	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	31.04	18.63	6.21	18.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	23.26	13.75	8.46	4.23	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.08	9.79	6.53	4.49	1.06	0.24	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	9.96	9.96	9.96	4.69	0.00	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	20.54	26.98	12.49	7.10	2.84	2.75	0.28	0.19
Keratinocyte - oral, donor1	11251-116E9	26.45	30.88	12.03	8.17	2.95	1.02	0.23	0.34
Keratocytes, donor1	11527-119I6	9.97	6.88	11.00	6.19	0.34	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	3.52	2.34	2.34	1.17	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	23.71	33.00	38.93	23.71	2.96	2.37	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	21.98	26.37	19.78	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	3.24	1.08	4.31	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.30	12.92	6.00	3.81	1.73	0.12	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	55.80	15.74	12.92	9.49	4.24	0.10	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.75	5.69	5.22	2.96	0.47	0.47	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.65	1.95	2.23	3.35	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.86	3.31	3.94	3.62	1.26	0.94	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.30	3.76	2.15	1.61	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.88	2.84	1.58	1.89	1.26	0.32	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.79	1.51	1.62	1.40	0.54	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	4.10	3.28	2.05	0.82	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	0.76	0.25	0.51	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.19	2.11	1.13	1.97	0.14	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	5.14	3.16	1.98	1.58	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	1.94	2.13	2.52	1.16	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.04	1.30	1.67	0.93	0.19	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.36	3.14	3.14	1.39	0.70	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.63	2.39	1.19	1.67	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.08	1.92	0.96	1.10	0.41	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.39	3.70	4.00	2.77	0.92	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.30	1.87	0.94	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.49	1.46	1.65	2.01	0.37	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.91	5.27	3.95	1.97	0.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	1.46	2.34	0.59	0.29	0.59	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.74	1.24	1.00	0.75	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	1.94	4.36	3.39	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.89	2.15	1.35	0.81	1.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.90	2.27	1.82	2.57	0.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	3.11	1.56	2.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	13.61	2.09	2.93	1.05	0.42	0.42	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.96	2.26	1.50	1.95	0.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	3.44	2.75	3.44	2.75	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.04	1.88	1.51	1.69	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.98	2.65	1.27	0.95	0.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	4.36	2.91	1.45	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.93	1.32	2.98	1.32	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.47	1.98	1.49	1.24	0.50	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.40	4.44	5.92	4.07	0.00	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.17	2.22	1.24	1.73	0.49	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.26	1.37	1.92	1.24	0.27	0.27	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.40	4.50	4.50	3.54	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.17	4.26	2.43	1.52	0.91	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.66	3.78	2.66	1.96	0.14	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.11	4.27	3.91	3.20	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	1.94	0.97	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.18	1.56	0.47	1.09	0.00	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.03	3.22	3.94	1.79	1.07	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.19	2.29	1.63	1.63	0.00	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.06	1.18	0.71	0.24	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.88	4.08	3.34	2.35	0.74	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.61	1.54	1.54	0.00	0.51	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.39	0.90	3.28	1.19	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	9.06	9.06	6.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.97	14.58	6.90	5.37	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	14.84	4.45	4.45	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	8.46	5.08	5.50	0.85	2.12	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	5.63	16.18	4.22	4.22	0.70	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	13.08	1.87	2.80	0.00	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.67	7.73	4.64	5.67	1.03	3.09	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	10.71	8.33	2.38	0.00	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.95	10.63	8.37	4.52	1.13	0.23	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.51	12.80	6.11	5.23	1.16	2.91	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	11.25	9.00	9.45	8.55	1.80	2.70	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.72	14.50	7.99	7.72	1.08	0.54	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.78	8.73	11.30	5.14	1.03	1.54	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.88	15.53	9.88	5.65	2.12	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.66	11.99	4.00	6.66	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.30	15.79	11.21	7.64	0.00	3.57	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.47	18.68	7.20	7.74	1.07	1.07	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.58	19.46	7.18	7.56	0.94	2.08	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13.50	12.88	6.14	6.75	0.61	1.84	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	18.75	10.60	6.52	1.63	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.62	21.24	10.20	4.79	1.25	1.87	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.82	15.13	9.81	7.57	1.12	8.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	16.49	8.24	4.12	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.58	15.97	6.68	8.13	1.45	4.94	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	22.12	15.84	6.28	7.17	0.90	2.39	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	20.47	19.36	11.62	8.30	0.55	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.26	14.14	8.13	5.30	0.71	1.41	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.23	16.60	6.27	5.90	2.21	2.58	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	9.21	8.06	5.76	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.35	15.35	11.51	5.76	1.54	2.30	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	16.42	6.23	5.10	0.57	6.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	9.03	5.74	4.92	0.82	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.36	16.27	8.59	4.52	0.45	2.71	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	8.62	6.46	7.18	0.72	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	11.95	7.47	8.22	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.52	16.35	8.18	3.72	1.11	3.72	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.77	18.52	9.05	5.60	0.43	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	8.56	18.84	11.99	1.71	0.00	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.66	14.66	6.66	6.66	1.00	2.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	9.65	11.46	4.83	1.81	2.41	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	12.09	8.53	7.11	2.13	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.66	13.75	7.91	3.09	1.03	2.41	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	7.51	5.90	6.98	5.37	1.07	4.29	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	12.79	7.41	7.41	0.00	2.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.85	12.59	5.19	5.56	0.74	2.96	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	17.44	9.30	4.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1.06	14.81	4.23	5.29	1.06	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.00	16.01	8.00	7.20	1.20	2.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	12.36	8.72	5.09	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	14.56	9.20	3.83	3.83	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.35	11.35	3.95	5.43	2.47	2.47	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	11.29	4.70	4.70	1.88	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.08	14.58	7.54	6.54	0.00	3.52	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.62	16.22	8.56	6.31	0.45	1.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	8.61	10.33	3.44	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.81	15.14	6.68	4.01	0.45	2.23	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.08	20.72	9.78	5.87	0.78	1.96	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	11.22	8.58	3.30	0.66	1.32	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.53	14.53	11.94	10.38	1.04	1.04	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.57	13.56	12.25	4.38	1.31	3.50	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	17.89	5.59	6.15	2.24	2.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.11	21.20	9.27	10.16	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.43	25.84	8.49	6.56	1.16	2.70	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.22	13.67	7.60	3.54	0.51	5.57	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.38	17.30	14.42	8.65	0.96	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.70	13.52	7.55	9.54	0.80	2.78	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	19.44	7.90	3.04	1.22	3.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	13.83	7.61	6.23	1.38	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	19.00	17.86	9.50	4.18	2.28	3.42	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.14	18.59	8.78	6.71	2.07	3.61	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.95	12.09	10.88	7.86	4.84	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	19.65	8.87	7.61	1.27	2.54	0.00	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	18.13	13.33	8.53	2.13	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	10.92	13.22	4.60	0.00	1.15	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.00	20.06	9.77	6.17	3.09	4.11	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	22.64	13.44	8.49	8.49	2.83	2.12	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	15.32	7.94	10.21	0.57	2.84	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.56	21.22	10.82	9.57	1.25	1.66	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	16.44	7.83	10.18	2.35	5.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.79	9.19	8.77	5.43	1.67	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.19	13.94	8.36	7.43	0.46	0.93	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	15.39	10.70	6.69	2.01	3.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.39	16.57	6.42	6.95	2.14	4.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.82	16.57	11.31	7.27	1.21	3.23	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	22.94	10.10	4.59	2.75	3.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	12.45	11.56	9.78	7.11	4.45	0.89	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	29.63	24.50	18.24	9.12	1.14	1.71	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.17	9.97	10.74	5.37	1.53	1.53	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	15.32	12.04	7.66	1.64	2.19	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.25	20.49	15.15	9.80	0.89	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	25.74	34.05	13.52	9.62	1.04	1.04	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.93	17.24	9.95	4.64	1.99	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	22.86	10.39	12.47	0.00	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	4.79	9.57	5.24	7.07	0.68	0.46	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.61	10.64	2.57	1.84	1.47	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	5.11	11.01	5.64	6.29	0.26	0.39	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	5.84	3.72	5.84	0.00	0.00	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	12.83	6.65	4.12	8.71	0.79	0.48	1.11	0.00
Mallassez-derived cells, donor3	11930-125I4	15.71	7.37	8.20	5.42	2.36	0.42	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	104.63	33.18	17.24	6.38	6.78	1.00	0.30	0.40
Mammary Epithelial Cell, donor2	11350-117G9	42.27	23.16	8.69	6.08	3.76	1.16	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	11.22	3.74	3.49	2.49	0.50	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	88.13	24.41	10.85	12.20	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	28.66	14.71	8.00	7.14	1.95	0.22	0.11	0.00
Mast cell, donor2	11565-120D8	8.92	13.37	5.35	9.21	2.38	0.30	0.30	0.00
Mast cell, donor3	11566-120D9	12.16	13.96	3.83	7.43	1.35	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	9.22	12.06	4.08	8.16	1.77	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	40.25	19.85	10.31	7.10	3.77	1.11	0.33	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	151.76	17.51	7.59	4.67	2.33	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	18.36	13.77	6.77	6.54	2.52	0.80	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	55.73	9.54	7.36	5.69	2.51	0.67	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	15.82	11.94	11.14	6.07	0.90	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	9.00	6.92	3.46	2.77	0.35	1.04	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	14.49	11.66	9.13	10.50	2.03	0.29	0.29	0.07
Melanocyte - light, donor1	11274-116H5	10.11	5.88	8.23	4.70	1.18	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	2.73	1.36	3.41	2.05	0.68	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	5.20	8.67	2.60	2.60	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	5.94	11.25	11.45	10.31	1.87	0.52	0.21	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	13.45	8.88	11.30	6.99	0.81	0.81	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	6.96	12.86	13.93	11.25	0.80	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	25.68	8.31	11.29	4.09	2.61	0.00	0.12	0.12
Meningeal Cells, donor2	11573-120E7	30.37	12.32	9.68	7.48	1.32	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	57.38	10.68	10.02	5.30	3.59	0.73	0.24	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.10	10.55	3.71	3.14	2.28	0.57	1.14	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	52.13	17.81	19.02	12.08	3.62	0.50	0.50	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	2.63	2.63	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	2.62	1.31	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	23.68	15.79	9.33	4.31	4.31	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.44	19.06	23.08	23.93	3.18	1.91	1.91	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	18.60	7.54	10.56	12.06	3.02	0.50	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.79	3.96	3.96	2.42	0.88	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	3.65	1.46	1.46	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.57	2.25	3.48	1.02	0.61	0.41	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.05	7.20	3.74	1.94	2.22	0.14	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.60	2.23	2.60	1.86	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.05	31.45	21.71	13.03	2.11	0.66	0.79	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.23	6.23	3.56	1.48	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	7.01	9.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	3.84	2.56	0.00	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.82	15.60	7.80	4.25	3.19	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	27.83	26.27	18.45	14.07	1.88	0.94	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	13.06	6.53	2.90	2.18	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	16.18	9.28	10.87	6.89	2.92	0.53	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	13.51	6.51	7.51	9.01	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.59	6.21	5.64	7.23	0.94	0.36	0.00	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	16.20	0.00	5.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.16	5.17	5.17	1.48	1.48	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.24	6.77	3.83	2.94	0.88	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.89	3.72	2.17	2.48	1.86	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.15	9.54	2.49	2.70	1.04	0.21	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	4.63	0.00	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	5.26	4.75	5.51	3.25	1.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	5.59	8.38	2.79	2.33	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	4.47	5.08	2.03	2.44	1.42	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.34	8.71	0.79	2.77	1.19	0.79	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	1.77	0.88	1.77	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.18	7.98	2.28	3.80	1.14	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	3.95	1.32	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	2.76	2.33	2.12	1.06	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	4.60	4.60	3.68	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.58	2.68	2.68	3.28	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.51	3.51	3.01	1.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.28	6.18	3.09	2.61	0.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	2.21	0.55	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.38	2.30	2.76	1.61	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.73	5.68	2.52	2.73	0.63	0.21	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.83	3.87	2.24	1.43	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.00	2.36	2.57	2.57	0.64	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	4.22	1.11	2.45	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.97	1.31	1.97	1.53	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	2.03	1.52	1.52	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.90	2.99	0.54	1.90	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.47	5.29	2.06	2.94	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	0.00	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	2.40	1.92	2.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.80	1.60	1.60	2.00	0.80	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.00	1.00	2.00	1.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.44	0.88	1.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	1.10	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	1.28	0.00	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.49	1.49	0.99	1.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	1.39	0.00	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	0.00	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.08	0.68	1.03	0.34	0.34	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.38	0.44	0.88	1.31	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	1.07	0.36	0.71	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.09	2.81	1.96	1.40	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.57	2.91	0.42	0.42	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	1.17	1.75	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.22	3.32	3.32	0.90	1.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.76	2.92	1.25	1.25	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1.85	1.85	4.62	1.85	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.85	5.12	2.28	2.85	1.14	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1.11	2.21	1.66	0.55	0.69	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.85	2.07	2.85	0.26	0.78	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.00	3.00	2.57	1.72	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.91	0.64	2.54	0.64	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.07	1.87	2.14	0.27	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.29	5.99	3.89	4.79	1.50	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.85	1.98	2.12	1.13	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.96	2.87	2.55	0.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.20	4.20	3.10	0.66	0.44	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.28	4.93	1.14	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	4.55	4.83	3.41	0.85	0.85	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	4.18	4.92	2.95	1.72	1.72	0.74	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	2.61	2.61	0.65	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1.18	3.23	4.70	0.88	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.32	8.65	4.90	2.88	0.86	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.89	4.53	3.30	1.65	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.08	5.06	2.68	1.49	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	11.30	0.00	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	3.56	5.35	1.78	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2.30	10.19	4.27	4.27	0.33	1.64	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	5.26	4.21	6.31	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.35	7.31	4.35	6.72	0.99	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	10.24	12.11	18.63	31.66	1.86	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.38	8.26	6.76	12.02	2.63	0.38	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.13	6.66	3.20	2.93	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2.15	4.98	4.86	4.30	0.45	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1.47	1.47	3.68	4.42	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1.83	5.13	4.76	7.33	0.37	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	3.11	1.56	7.78	3.11	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	4.81	3.21	4.28	1.07	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	6.06	4.04	3.03	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.11	7.17	2.53	5.48	1.26	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	0.00	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	1.27	0.64	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	2.43	4.05	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	6.04	1.51	6.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	0.00	3.26	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	63.12	17.23	27.36	18.31	3.23	1.72	1.94	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	44.42	27.70	17.77	18.29	6.27	4.18	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.69	5.34	1.33	5.34	2.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	7.93	6.26	7.10	2.09	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	42.59	8.75	5.70	1.90	3.42	1.71	0.00	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	7.98	1.60	4.79	1.60	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	3.40	3.40	4.76	2.72	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	77.18	18.38	5.51	11.03	9.19	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.49	6.28	3.35	4.19	2.09	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.50	4.65	5.58	4.42	1.16	0.23	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.56	2.97	3.51	3.51	1.62	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.03	5.26	4.20	1.89	2.31	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	0.00	0.00	0.00	11.13	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.90	7.94	0.99	4.47	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.68	6.50	2.17	4.60	1.62	0.00	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	5.67	2.95	3.63	1.81	0.68	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.80	3.59	4.25	3.43	1.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	12.94	7.11	4.01	4.74	3.28	1.09	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	5.30	3.18	3.18	2.65	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.01	3.60	6.00	4.80	1.20	0.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	25.60	9.19	2.63	3.94	2.30	1.31	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.55	3.58	4.39	3.90	1.30	0.33	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.75	9.52	6.35	3.88	2.12	0.53	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	1.41	3.52	5.63	2.11	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	6.44	3.68	2.30	1.38	1.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.21	8.03	2.89	7.07	2.57	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.11	14.14	8.97	4.83	2.07	2.41	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	32.87	10.11	17.70	7.59	5.06	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.51	9.58	3.12	4.23	2.23	0.22	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	4.66	6.77	7.62	2.96	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.38	6.17	2.85	5.22	1.19	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	39.92	15.88	12.45	10.73	4.29	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	45.14	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	30.66	8.66	9.00	11.00	4.67	1.00	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.91	9.92	11.27	4.51	1.35	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	35.32	7.14	5.56	9.52	1.98	3.57	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	9.29	1.86	5.57	3.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.95	15.89	7.19	11.35	3.41	3.03	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	39.11	10.43	12.38	13.69	3.26	1.30	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	24.40	10.02	14.82	13.07	2.18	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.92	13.12	9.95	8.14	1.81	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	36.16	13.23	12.35	19.40	0.88	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	5.98	2.66	6.65	3.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.34	13.39	8.93	7.94	0.99	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	31.01	12.25	18.38	17.61	2.68	0.38	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.11	19.66	14.21	6.65	3.63	1.21	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.95	12.38	10.17	5.75	2.43	0.44	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	26.43	8.81	10.84	13.55	4.07	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	30.66	5.11	10.22	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.26	18.90	12.19	15.24	2.44	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.09	12.27	17.31	18.57	2.83	0.63	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	21.19	13.92	13.92	15.13	2.12	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	15.82	7.12	3.16	1.58	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	66.88	28.34	10.20	10.20	4.53	2.27	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	25.29	5.06	15.17	15.17	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	32.55	9.57	7.33	4.35	2.24	0.62	0.00	0.25
Myoblast, donor2	11322-117D8	27.04	11.51	5.37	5.75	1.73	0.58	0.19	0.19
Myoblast, donor3	11398-118D3	42.71	10.43	3.53	5.55	3.70	0.17	0.67	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.81	31.52	62.75	28.46	1.75	1.75	0.00	0.44
Natural Killer Cells, donor1	11230-116C6	13.53	11.38	3.69	4.92	0.62	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	14.17	11.16	4.22	2.41	0.90	1.51	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	9.57	14.72	6.81	4.97	1.10	0.18	0.00	0.18
Neural stem cells, donor1	11275-116H6	43.55	21.05	10.53	4.72	1.81	0.00	0.00	0.36
Neural stem cells, donor2	11352-117H2	19.26	38.51	11.55	5.78	3.85	0.00	1.93	0.00
Neurons, donor1	11494-119E9	19.34	18.21	5.69	5.69	0.00	4.55	1.14	1.14
Neurons, donor2	11574-120E8	10.57	17.83	5.72	3.74	1.54	0.88	0.22	0.00
Neurons, donor3	11655-122E8	18.09	12.33	4.93	3.29	4.93	3.29	0.00	4.11
Neutrophils, donor1	11233-116C9	1.86	7.42	0.00	1.86	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	5.80	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	1.83	1.22	1.83	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	11.16	8.67	4.04	5.94	0.71	0.12	0.71	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	9.44	1.63	1.30	2.60	0.33	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	18.05	14.84	12.84	11.63	3.61	0.60	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	32.07	19.96	13.49	8.26	3.58	1.10	0.41	0.69
Olfactory epithelial cells, donor2	11934-125I8	38.94	21.28	11.87	8.68	4.20	8.40	0.87	0.43
Olfactory epithelial cells, donor3	11935-125I9	44.61	29.85	18.39	15.44	5.11	1.59	0.45	0.23
Olfactory epithelial cells, donor4	11936-126A1	41.98	37.40	24.84	19.28	5.84	0.97	0.78	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	26.48	15.65	10.23	7.22	2.41	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	34.03	18.93	12.34	11.06	5.32	0.00	0.64	0.85
Osteoblast - differentiated, donor2	11353-117H3	14.86	3.43	2.29	11.43	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	32.90	23.59	15.52	10.55	4.34	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	29.90	9.38	3.32	1.76	1.95	0.20	0.39	0.20
Osteoblast, donor2	11354-117H4	58.29	18.26	11.24	8.43	4.92	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	47.63	15.64	10.49	7.64	4.27	1.96	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	27.63	12.64	7.83	9.60	2.61	1.10	0.84	0.08
Pericytes, donor1	11491-119E6	3.12	1.00	1.22	0.45	0.33	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	3.40	1.36	1.58	1.81	0.68	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	16.48	4.88	5.09	4.48	1.83	1.02	0.20	0.20
Perineurial Cells, donor1	11499-119F5	51.99	18.65	12.88	8.36	3.16	0.79	0.11	0.00
Perineurial Cells, donor2	11579-120F4	15.00	10.40	5.98	4.42	1.75	0.28	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6.37	11.16	5.10	5.10	1.91	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.37	10.77	1.96	2.94	0.98	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	6.34	11.91	5.56	3.88	1.04	0.00	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	8.13	3.11	1.43	2.15	0.48	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	16.63	9.98	9.98	4.44	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.37	3.53	1.37	4.32	0.98	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	42.72	11.39	12.66	11.08	2.85	5.06	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	85.35	17.82	18.76	12.38	3.75	0.94	0.38	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	113.17	10.83	10.31	5.61	5.61	0.91	0.26	1.70
Preadipocyte - breast, donor2	11328-117E5	62.37	19.36	15.31	12.38	5.40	2.70	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	103.04	30.48	23.66	18.33	7.25	1.17	0.85	2.13
Preadipocyte - omental, donor2	11329-117E6	54.56	20.95	18.77	11.78	4.36	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	79.79	23.92	15.76	14.18	5.59	1.72	0.72	0.86
Preadipocyte - perirenal, donor1	11469-119C2	18.70	3.94	3.94	2.95	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	31.02	7.68	8.29	3.07	2.15	0.31	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	38.43	15.41	8.85	8.68	5.49	1.95	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	32.69	14.47	8.68	6.30	3.07	1.36	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	55.80	19.10	11.55	7.36	5.59	0.75	0.37	0.37
Preadipocyte - visceral, donor2	11357-117H7	24.39	10.12	5.52	4.14	3.22	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	25.91	6.79	5.54	5.85	3.24	1.15	0.21	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	18.10	19.46	10.71	6.03	2.26	0.60	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	10.43	4.60	3.66	3.93	0.81	0.54	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	13.47	34.54	23.03	19.17	2.45	1.84	1.16	0.18
Prostate Stromal Cells, donor1	11254-116F3	51.82	21.75	19.36	20.05	5.47	1.25	2.51	0.34
Prostate Stromal Cells, donor2	11332-117E9	40.52	24.03	19.90	15.96	3.59	5.56	1.43	0.36
Prostate Stromal Cells, donor3	11405-118E1	22.21	17.00	10.95	10.11	1.88	0.83	0.94	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.92	5.47	3.28	2.55	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.50	11.58	4.51	2.08	1.94	0.49	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	5.07	4.06	3.04	1.52	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	0.71	1.42	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	15.67	7.94	5.82	4.45	1.59	0.32	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	1.36	3.40	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.36	2.56	2.56	1.89	0.94	0.13	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.09	8.21	5.33	4.00	2.00	1.55	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	2.00	1.33	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.74	3.08	1.98	1.32	0.88	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	2.51	4.39	1.25	1.25	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.77	1.39	0.55	0.55	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.32	7.52	4.03	3.22	1.07	0.00	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.22	5.48	2.11	5.06	1.27	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.36	3.47	1.16	0.96	1.74	0.58	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.26	10.63	7.52	3.63	2.07	0.78	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5.97	2.84	5.97	1.42	0.28	0.00	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	2.06	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	48.68	15.31	15.81	7.53	1.76	0.25	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	12.29	20.98	12.43	7.62	0.40	0.13	0.13	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	59.86	46.46	26.80	1.79	0.89	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.32	35.77	46.78	14.31	3.85	5.50	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	35.96	32.48	52.20	15.08	6.96	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.69	30.82	23.14	8.19	3.38	0.52	0.26	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	35.65	31.68	23.24	13.90	3.77	1.49	0.10	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	48.41	37.25	32.57	15.95	5.02	0.67	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	43.29	36.84	29.27	13.15	6.33	1.24	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.23	40.56	27.27	14.22	4.43	2.21	0.12	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	35.59	42.53	32.59	13.41	3.47	1.85	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.74	29.44	21.91	12.05	5.34	1.23	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	35.70	34.79	21.03	10.29	4.69	2.42	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.86	41.21	32.79	13.80	4.66	1.08	0.18	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	28.98	29.27	21.52	11.48	4.16	2.01	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.37	33.37	23.93	12.45	3.11	1.50	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	35.85	34.08	24.56	12.83	3.32	0.66	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.85	23.51	19.69	7.65	3.44	1.91	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	32.79	34.66	22.55	10.62	4.10	0.93	0.09	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	58.06	42.28	37.21	14.66	4.13	0.94	0.19	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	39.28	30.92	21.37	10.35	4.51	0.40	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	43.32	36.60	22.68	10.90	4.77	1.36	0.19	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	40.48	38.57	28.07	11.84	4.96	0.76	0.38	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	38.13	29.37	22.75	9.18	4.06	0.85	0.21	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	34.76	37.56	20.74	10.37	3.08	3.64	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	43.41	37.26	28.03	10.25	3.93	1.71	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	40.30	26.62	16.59	8.93	4.01	0.91	0.36	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.57	31.52	22.81	11.40	3.07	1.35	0.12	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	40.56	37.21	27.67	13.30	3.49	1.34	0.13	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	31.14	23.35	19.81	11.79	5.66	1.42	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	41.47	35.91	23.41	12.90	3.97	2.18	0.00	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	48.41	37.65	27.83	10.99	4.91	0.47	0.00	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	29.24	26.13	22.81	12.03	6.01	1.45	0.00	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	45.35	31.63	24.55	10.18	3.54	4.87	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	44.28	33.21	26.95	12.74	3.55	1.04	0.42	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	43.87	30.42	21.40	10.23	5.52	1.35	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	43.94	27.76	20.09	8.69	2.90	0.68	0.00	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	47.04	32.00	22.17	13.50	6.17	1.54	0.19	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.75	21.32	15.82	7.57	5.50	1.20	0.86	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	44.72	25.10	16.05	9.33	3.84	1.10	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.10	32.01	16.91	8.21	3.45	2.46	0.33	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.09	21.99	15.51	8.69	3.07	1.87	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.25	33.14	19.97	11.39	3.55	1.18	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.99	30.12	24.79	9.86	1.60	0.53	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.99	45.63	52.26	24.06	4.15	1.38	0.69	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.29	33.81	17.62	12.62	2.38	0.71	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.39	36.68	25.80	12.50	2.42	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.94	25.52	24.58	10.26	2.83	1.51	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	53.10	71.97	74.06	37.03	4.54	3.49	2.45	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	46.54	53.49	59.23	30.52	6.35	2.72	0.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	21.54	22.03	15.91	6.73	1.96	1.22	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	110.18	74.96	97.23	44.39	4.66	1.60	0.73	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	51.72	49.89	58.41	26.77	6.69	1.83	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	20.50	20.19	14.47	6.03	1.51	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	48.86	60.17	66.50	30.76	3.39	2.49	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.73	55.12	60.81	27.26	5.69	1.20	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	40.26	32.35	46.88	14.76	4.72	1.65	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	49.73	45.46	64.46	24.12	5.55	1.49	1.28	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.89	45.67	52.89	29.45	4.81	3.00	1.20	2.40
Schwann Cells, donor1	11498-119F4	9.78	3.20	2.63	1.50	0.38	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	13.61	6.80	6.80	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.87	6.35	4.16	3.29	1.53	1.75	0.44	0.00
Sebocyte, donor1	11220-116B5	25.20	13.69	7.12	10.41	2.74	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	11.49	8.27	5.97	5.06	1.84	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	8.24	9.07	5.98	6.80	0.82	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	62.95	36.45	18.22	9.94	6.63	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	62.14	8.47	14.12	11.30	0.00	19.77	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	54.81	23.84	15.22	11.79	7.39	0.18	0.26	0.09
Skeletal Muscle Cells, donor2	11358-117H8	28.19	11.57	5.78	5.06	3.61	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	3.34	0.84	2.51	3.34	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	33.30	15.71	8.64	5.66	4.08	1.26	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	29.58	13.08	9.51	5.05	2.38	1.19	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	36.17	14.47	13.08	7.39	5.39	1.54	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	45.61	20.03	10.46	8.06	5.80	1.01	0.13	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	24.83	13.13	4.00	5.85	2.28	1.43	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	37.60	20.54	12.20	7.24	4.56	1.69	0.00	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	57.12	20.22	15.33	8.34	4.63	1.43	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	27.50	14.48	5.07	7.96	3.62	1.45	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.04	4.13	1.93	0.83	1.38	0.14	0.00	0.14
Skin - palm, donor1	10286-104F7	8.06	2.69	0.00	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.94	4.18	4.18	3.17	1.44	0.43	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	12.27	13.09	10.63	4.91	3.27	3.27	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.41	5.58	4.54	2.73	2.47	0.39	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	49.35	29.61	21.69	12.93	3.89	0.28	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	38.82	25.60	13.93	6.61	4.64	2.11	0.70	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	46.94	17.97	9.09	5.71	3.81	0.00	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	26.38	43.32	25.63	17.16	3.60	1.35	0.75	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.76	6.48	9.57	7.71	4.94	4.63	0.00	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.02	5.56	6.67	5.78	6.23	0.44	0.67	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.09	8.82	3.53	5.29	2.94	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.46	4.64	3.98	1.33	3.31	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.45	2.76	3.94	3.54	0.79	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	5.41	6.95	4.64	3.86	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	9.01	1.00	3.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.69	5.99	5.86	3.33	1.20	0.00	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.70	11.75	10.42	7.76	2.44	1.55	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	48.52	13.19	12.16	13.70	3.97	1.15	1.02	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.37	8.47	4.88	3.91	0.33	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.33	11.81	7.09	5.32	1.18	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.66	9.25	8.26	4.41	2.14	0.71	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.60	2.60	1.30	1.46	0.65	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	29.83	14.31	15.22	6.70	3.35	1.22	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	30.81	10.61	3.54	2.78	2.27	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	2.86	2.86	1.91	0.95	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.66	8.85	5.90	4.13	0.88	0.44	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.43	6.67	5.81	4.30	2.15	0.65	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.25	12.59	6.82	4.20	2.52	0.63	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.77	4.02	3.09	2.63	1.55	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	6.47	4.31	4.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.46	4.18	1.49	1.49	1.49	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.39	3.07	2.05	2.73	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.08	18.93	10.84	7.15	4.55	0.94	0.24	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	44.28	12.38	8.35	8.15	3.32	0.40	0.20	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.57	5.23	10.01	3.41	1.82	1.82	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	3.62	3.02	3.02	2.42	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	39.74	16.43	15.90	8.48	2.65	0.79	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.02	18.78	14.38	10.39	5.33	0.67	0.80	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	38.07	20.91	16.28	10.02	4.13	1.50	1.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.20	8.62	5.58	9.13	2.03	1.27	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.60	12.51	7.24	4.37	2.71	0.45	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	9.00	4.50	1.50	3.00	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	33.60	6.46	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	10.70	2.79	5.58	3.72	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.17	3.03	4.04	2.52	1.51	0.00	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	2.82	5.33	1.25	0.94	0.31	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.88	0.88	1.18	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	46.24	13.66	10.58	5.91	4.08	0.08	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.68	5.14	4.20	4.20	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.40	6.91	7.48	3.89	0.72	0.00	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.30	8.16	4.08	4.08	2.29	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	15.42	5.64	4.14	2.26	1.69	0.38	0.75	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.63	10.20	5.17	6.71	2.66	0.98	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	52.79	16.93	9.80	11.65	4.36	0.25	1.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	5.71	1.90	1.90	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.15	6.61	6.12	4.65	1.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.61	9.72	5.97	5.97	3.98	0.44	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	24.87	12.00	6.44	2.34	2.05	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.10	12.44	14.19	10.88	3.89	0.78	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.60	6.88	11.64	10.58	2.64	1.85	1.85	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	4.46	1.49	2.98	0.74	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.55	8.62	6.11	7.55	0.72	1.44	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.23	2.84	5.11	4.26	0.57	1.14	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.63	10.63	11.03	7.48	5.12	3.54	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	16.25	9.40	11.68	6.35	3.81	2.29	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	6.39	9.98	7.99	9.98	0.80	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	8.78	15.05	10.03	2.51	1.67	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	11.92	18.79	16.04	10.54	4.13	1.83	0.00	0.00
Synoviocyte, donor1	11291-117A4	52.18	12.46	11.28	10.10	3.70	0.34	0.34	0.34
Synoviocyte, donor2	11368-117I9	20.95	16.59	5.70	8.38	2.51	1.84	0.34	0.34
Synoviocyte, donor3	11440-118H9	23.90	13.40	4.47	6.03	2.68	1.12	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	11.08	2.14	3.57	2.50	0.71	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	5.95	7.93	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.44	6.02	9.49	3.47	0.69	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.20	22.01	12.97	6.52	2.94	0.22	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	8.12	8.50	1.93	3.09	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	11.45	5.73	5.15	4.01	2.29	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	9.96	19.07	11.32	8.37	1.35	0.25	0.12	0.12
Urethra, donor2	10319-105A4	3.60	10.79	3.60	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.39	4.25	2.66	0.80	0.53	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.41	2.40	1.20	1.60	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.35	2.75	2.06	0.46	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	19.84	16.94	6.69	4.24	2.90	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	6.23	9.79	2.67	1.78	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	4.29	7.15	5.72	4.29	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	1.37	6.16	3.42	2.74	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.20	12.40	3.10	3.10	1.38	0.34	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	7.55	5.81	3.49	1.74	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	7.29	14.58	2.08	1.04	5.21	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	5.51	8.26	8.26	2.75	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	2.74	10.04	4.56	3.65	0.00	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	37.63	32.32	11.72	11.72	4.56	1.11	0.49	0.62
Wilms' tumor cell line:HFWT	10597-108E3	36.08	33.44	61.60	41.36	2.64	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.92	23.74	10.61	10.33	0.84	0.00	0.28	0.00
achilles tendon, donor2	10292-104G4	6.20	0.00	0.00	6.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.26	27.79	22.95	11.22	5.35	1.78	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.84	53.40	24.61	20.66	4.18	0.23	0.00	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	51.99	56.15	55.67	31.22	3.21	0.83	0.71	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	21.22	37.55	40.00	28.30	2.72	1.90	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	12.37	12.65	7.31	4.22	1.41	1.69	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.32	12.90	6.77	9.31	1.69	0.21	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	57.16	31.30	29.94	31.30	3.81	0.82	0.54	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	26.88	29.52	25.56	11.90	2.20	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	58.80	21.64	7.76	5.72	1.63	3.68	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.24	18.64	19.41	10.48	4.27	0.78	0.00	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	28.89	40.48	24.66	20.24	1.29	3.68	1.29	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	19.50	19.50	11.70	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.34	16.27	8.60	6.97	3.49	1.86	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	52.56	37.02	23.56	17.09	4.92	2.85	0.00	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	48.51	45.01	27.76	14.61	2.63	4.09	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	36.25	21.84	11.15	9.76	2.32	0.46	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.08	31.26	29.20	13.16	2.88	2.88	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.52	8.29	17.19	7.06	0.92	0.31	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.47	27.74	20.06	11.95	1.28	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	28.81	32.45	15.47	13.04	3.03	0.91	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	33.46	29.61	19.26	11.55	2.41	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	29.85	23.61	25.17	8.24	3.34	1.78	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.02	30.02	17.68	9.67	3.34	0.33	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	74.33	52.03	27.87	18.58	5.57	0.00	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	31.26	28.63	29.38	16.95	2.64	0.38	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.71	30.97	11.78	10.47	1.74	1.31	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	16.87	7.50	7.50	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	12.01	43.10	20.02	13.19	2.59	0.71	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	9.00	14.58	5.12	6.83	0.62	0.16	0.16	0.16
adipose, donor1	10184-103D4	26.97	34.60	11.14	4.69	0.59	1.76	0.00	0.00
adipose, donor2	10185-103D5	15.82	12.98	2.03	4.06	0.00	0.41	0.41	0.00
adipose, donor3	10186-103D6	23.14	19.06	5.72	3.27	2.45	2.45	0.00	0.54
adipose, donor4	10187-103D7	24.27	45.94	14.73	6.07	1.73	6.93	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.68	32.35	16.73	24.62	1.26	0.32	1.42	0.00
adrenal gland, adult, pool1	10081-102A9	0.00	7.28	3.64	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	21.34	19.08	16.68	18.28	2.40	0.27	0.40	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	25.01	31.09	14.29	8.22	5.00	1.07	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	13.91	11.59	6.72	9.27	0.00	0.70	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	7.78	13.52	7.10	10.48	0.68	0.34	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	8.25	7.37	1.77	8.84	1.47	0.59	0.00	0.29
amygdala - adult, donor10196	10167-103B5	0.00	14.23	7.11	4.74	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	10.54	33.66	7.30	8.52	0.61	1.22	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	10.01	11.62	3.87	4.84	0.97	0.97	0.65	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	47.37	26.23	20.37	21.26	4.20	0.51	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.06	13.90	14.12	13.68	4.19	0.88	0.22	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	31.07	41.75	12.69	11.36	5.34	2.00	0.33	0.00
aorta, adult, pool1	10052-101G7	4.71	10.79	3.14	8.43	1.57	0.98	0.20	0.00
appendix, adult	10189-103D9	4.66	12.81	2.33	2.72	0.78	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.97	19.26	5.16	4.47	1.03	0.34	0.00	0.00
artery, adult	10190-103E1	0.00	2.72	1.36	1.36	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	28.54	37.23	29.26	16.95	3.77	1.01	0.29	0.14
b cell line:RPMI1788	10427-106D4	9.37	22.01	21.12	20.52	1.93	0.74	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.00	20.53	23.86	13.59	2.22	1.39	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	40.88	34.33	42.37	22.72	3.08	0.50	1.09	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	18.24	28.96	55.57	48.04	1.84	1.17	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	63.75	25.72	24.05	13.42	11.74	2.24	0.56	0.56
bladder, adult, pool1	10011-101C2	6.74	12.28	4.67	5.76	0.76	0.33	0.00	0.11
blood, adult, pool1	10053-101G8	6.64	0.00	2.21	8.86	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.98	5.99	4.28	2.57	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	14.17	10.12	7.42	6.75	0.67	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	10.25	19.48	5.13	10.25	0.00	0.00	2.05	0.00
brain, adult, pool1	10012-101C3	8.80	21.38	4.12	9.35	1.56	0.22	0.78	0.56
brain, fetal, pool1	10085-102B4	0.00	10.69	0.00	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	100.10	60.79	58.47	46.58	3.63	2.97	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	16.98	24.59	13.61	9.61	0.87	0.00	0.12	0.12
breast, adult, donor1	10080-102A8	3.16	23.36	9.47	13.89	2.53	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	46.37	56.28	26.42	39.38	2.54	1.78	0.64	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.26	29.38	10.20	6.49	2.16	0.62	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.83	17.50	4.37	6.22	0.92	1.15	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	22.27	14.28	5.33	2.66	1.45	0.73	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.05	45.14	25.39	13.16	0.47	1.88	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	59.50	86.96	88.49	58.74	6.13	1.64	1.20	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	13.63	37.39	22.18	7.61	2.54	1.27	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	44.19	37.26	32.74	21.56	4.53	3.73	0.80	0.80
caudate nucleus - adult, donor10196	10177-103C6	10.36	14.97	3.45	9.21	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	13.05	35.14	5.86	10.88	1.00	1.51	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	6.88	23.69	3.82	14.52	0.76	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	16.48	9.89	5.86	6.23	1.46	1.10	0.00	2.20
cerebellum - adult, donor10196	10173-103C2	2.91	26.22	2.91	29.13	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	7.69	38.43	7.05	9.82	0.64	0.85	0.21	0.00
cerebellum, adult, pool1	10083-102B2	6.90	17.94	4.14	10.00	0.34	0.69	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	9.96	11.62	6.64	12.45	0.00	0.83	0.00	1.66
cerebral meninges, adult	10188-103D8	7.56	18.15	5.29	7.56	0.50	0.50	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	4.39	5.85	0.73	1.46	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	20.42	44.28	38.10	34.08	1.87	0.58	2.16	0.43
cervical cancer cell line:ME-180	10553-107I4	95.29	42.42	30.82	27.34	4.81	1.49	0.99	0.33
cervix, adult, pool1	10013-101C4	13.02	14.49	4.20	5.77	1.47	0.31	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	30.65	22.43	28.29	25.50	3.07	1.81	0.42	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	15.68	7.84	5.23	2.61	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	26.47	76.18	58.41	24.23	4.35	1.74	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	9.24	54.95	99.80	48.42	1.11	3.08	1.97	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	6.88	41.51	34.15	16.60	2.37	0.24	1.42	0.24
chorionic membrane cells, donor1	12238-129G6	10.54	13.39	5.13	7.69	1.42	0.85	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	20.38	27.34	17.30	7.76	2.49	0.89	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	15.94	20.88	5.49	3.30	3.30	1.10	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	7.07	12.12	2.02	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.67	20.17	12.10	6.72	3.46	0.96	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	41.81	24.08	17.74	11.62	2.53	1.06	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	19.52	34.67	17.21	3.34	1.28	1.03	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	20.32	44.99	20.80	6.77	1.21	2.18	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.28	41.94	24.84	6.31	3.66	1.02	1.02	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	40.34	46.82	18.55	9.72	2.94	0.88	0.88	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	40.92	30.23	25.54	9.90	2.61	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.69	16.92	7.54	9.60	2.06	2.74	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	31.40	28.80	15.27	13.53	3.30	1.04	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	28.92	34.23	10.98	8.05	1.83	0.37	0.37	0.92
colon carcinoma cell line:COLO-320	10420-106C6	30.41	155.45	114.78	41.81	2.66	0.38	1.14	0.76
colon, adult, donor1	10082-102B1	4.76	10.71	0.00	7.14	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	6.93	9.75	3.64	4.70	0.94	0.00	0.00	0.12
colon, fetal, donor1	10070-101I7	1.85	4.33	2.47	6.80	1.24	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	174.17	18.33	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	142.78	56.52	35.69	18.70	5.95	2.12	2.55	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	75.01	28.98	15.40	10.72	4.53	0.45	1.21	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	70.79	27.36	13.11	9.87	4.37	0.99	0.71	0.56
corpus callosum, adult, pool1	10042-101F6	11.61	32.39	4.86	11.83	1.44	0.00	0.44	0.44
cruciate ligament, donor2	10295-104G7	7.29	5.67	3.24	3.24	0.00	0.00	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	7.22	15.25	2.41	3.21	0.80	0.80	0.00	0.00
diencephalon, adult	10193-103E4	3.36	15.36	4.32	7.20	0.72	0.00	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.77	40.64	26.41	15.38	2.07	8.50	0.00	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	61.03	68.21	53.34	29.23	3.59	0.26	1.54	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	35.15	34.42	29.61	15.41	2.17	1.44	1.44	0.24
ductus deferens, adult	10196-103E7	7.48	16.45	4.49	4.98	0.00	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	7.20	20.16	1.44	11.52	2.88	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	7.36	14.71	5.89	4.41	0.74	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	11.15	13.71	3.80	9.08	1.32	0.00	0.25	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	133.91	25.54	20.21	2.66	6.44	0.00	0.00	4.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	32.10	21.92	15.76	4.59	2.15	0.14	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	33.30	40.08	51.80	29.60	2.47	1.85	1.23	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	29.97	48.43	39.96	24.52	3.94	4.24	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	39.52	41.68	58.04	41.68	2.16	0.31	2.16	0.00
embryonic pancreas cell line:2C6	10603-108E9	34.15	45.97	53.85	27.58	5.25	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	44.58	29.16	20.11	27.82	1.68	0.00	1.68	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	39.15	58.72	35.70	30.81	3.99	3.62	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	4.02	7.56	8.84	5.31	0.00	0.80	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	34.24	31.79	25.46	18.79	2.56	0.00	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	40.47	24.75	19.69	8.47	2.53	0.66	0.66	0.22
epididymis, adult	10197-103E8	6.70	9.63	2.93	4.40	1.67	0.21	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.98	29.63	20.22	21.29	2.66	1.06	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	36.57	26.35	37.75	26.74	5.51	1.97	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.30	47.05	25.69	13.24	3.54	2.75	0.13	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	79.52	64.27	39.76	21.85	4.43	2.46	0.59	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	55.90	47.84	28.23	15.35	2.58	2.13	0.34	1.01
esophagus, adult, pool1	10015-101C6	11.25	11.68	2.87	5.52	1.49	0.21	0.32	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	60.36	49.47	108.58	101.82	1.63	0.50	4.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	9.66	4.83	9.66	2.41	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	0.00	4.21	2.10	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	5.95	0.00	2.98	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	6.88	5.73	1.15	1.15	0.00	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	5.83	4.37	2.91	5.83	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	9.66	17.80	4.83	8.39	1.27	1.27	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	37.83	27.82	14.10	10.26	5.39	1.54	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	34.90	22.55	22.55	17.81	7.36	0.47	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	9.01	27.58	5.91	13.98	1.60	0.28	0.47	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	63.35	39.03	22.22	14.71	3.90	2.10	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	32.73	34.93	13.72	9.24	3.75	0.46	0.18	0.46
gall bladder, adult	10198-103E9	5.07	8.93	1.45	2.17	0.72	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	17.72	13.42	8.05	3.76	2.15	1.61	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	8.96	7.10	5.98	3.73	0.00	0.37	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	64.63	46.47	49.21	21.54	4.86	9.29	0.84	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	38.68	74.85	78.91	81.23	1.35	4.26	2.13	0.39
gastric cancer cell line:AZ521	10549-107H9	42.14	80.01	71.65	35.41	5.41	0.33	1.31	0.49
gastric cancer cell line:GSS	10560-108A2	10.98	57.66	51.25	28.37	0.92	8.24	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.13	40.44	60.08	31.53	1.14	4.57	2.28	0.23
giant cell carcinoma cell line:LU65	10487-107B1	16.64	30.06	43.03	29.83	2.07	2.07	1.26	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	46.89	17.77	17.35	12.60	3.08	0.42	0.56	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	39.41	30.18	16.96	8.48	4.24	1.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	28.71	13.41	6.02	6.54	2.74	0.11	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	31.46	13.90	5.20	4.21	2.81	0.00	0.28	0.28
glioblastoma cell line:T98G	10485-107A8	32.67	23.29	18.10	8.50	1.99	0.77	0.11	0.55
glioma cell line:GI-1	10413-106B8	57.99	33.10	28.99	9.96	8.20	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	4.37	24.05	2.92	10.20	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	8.30	44.91	8.79	8.54	1.71	0.49	0.24	0.49
globus pallidus, adult, donor10258	10367-105F7	4.11	5.48	2.74	5.48	0.00	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.72	16.52	5.33	7.99	2.13	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	124.80	22.02	9.79	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	26.88	18.88	14.72	11.52	1.92	2.24	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	7.80	32.14	31.68	8.26	1.38	2.30	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	2.29	21.95	31.09	7.32	0.91	2.29	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	7.09	32.20	37.36	5.15	0.64	1.29	0.00	1.93
hIPS, biol_rep1	14380-156B6	5.75	23.00	35.93	5.75	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	5.49	24.01	34.29	6.86	0.69	2.06	0.00	0.69
hIPS, biol_rep3	14382-156B8	4.41	17.66	6.62	1.10	1.10	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	14.65	15.52	11.78	8.33	1.15	0.86	0.00	0.86
heart - mitral valve, adult	10205-103F7	5.98	12.56	2.99	4.19	0.90	0.00	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	5.49	10.20	1.57	6.01	0.26	0.52	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	19.98	12.49	8.33	5.83	3.33	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	7.14	34.28	29.79	23.47	1.63	3.67	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	1.28	6.81	1.70	2.13	0.85	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	5.29	11.04	3.68	6.67	0.46	0.00	0.23	0.23
heart, fetal, pool1	10046-101G1	7.39	20.54	5.96	6.88	0.72	0.10	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	36.41	25.61	13.88	12.34	2.78	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	53.51	40.43	49.95	28.54	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.84	40.33	17.90	9.94	1.33	1.33	0.00	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.55	38.72	18.93	8.01	1.34	1.70	0.00	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	31.12	45.37	20.72	7.88	3.54	1.31	0.30	0.61
hepatoma cell line:Li-7	10484-107A7	21.02	71.29	123.89	46.04	1.33	3.11	0.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.70	51.26	48.34	14.47	2.31	1.61	0.10	0.60
hippocampus - adult, donor10196	10169-103B7	7.57	16.09	5.68	7.57	2.84	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	11.63	33.88	6.74	9.39	0.82	0.82	0.41	0.41
hippocampus, adult, donor10258	10374-105G5	1.49	6.97	7.97	7.47	0.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	11.28	9.16	4.58	11.63	2.47	0.00	0.35	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.82	58.59	42.72	15.26	4.27	4.88	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.57	38.49	25.53	12.37	1.37	2.36	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	14.73	44.18	38.85	11.17	3.81	1.78	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.15	27.07	7.33	3.38	3.95	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	13.43	24.01	7.75	3.61	1.81	8.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	9.49	25.43	7.59	3.04	1.52	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.56	18.98	8.17	4.96	2.63	0.58	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	16.59	21.76	7.54	3.88	1.29	0.86	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.69	20.44	7.92	4.17	2.09	0.00	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.10	15.39	5.21	3.08	2.84	0.24	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.00	16.39	7.39	3.86	1.93	1.61	0.32	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.79	20.20	7.41	3.37	2.02	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.99	43.82	28.01	12.05	2.03	1.72	0.47	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	9.33	34.88	18.18	8.35	2.95	17.20	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.09	31.42	43.64	3.49	1.75	4.36	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.42	18.33	5.73	3.63	2.86	0.76	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.85	22.24	3.49	2.18	0.44	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.49	11.99	8.50	2.00	2.00	2.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.13	15.45	2.45	3.39	0.57	1.13	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	14.10	8.64	5.00	2.27	1.36	1.82	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.35	12.53	4.39	2.19	1.25	0.63	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.64	13.72	3.43	4.08	1.96	0.49	0.16	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.58	14.23	3.19	2.03	1.45	0.58	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.34	12.26	2.39	4.78	2.09	0.60	0.60	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.96	38.43	22.91	11.82	4.43	4.62	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.12	41.08	23.11	10.56	1.43	2.28	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	24.09	45.32	33.07	14.29	2.04	2.86	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	12.32	16.55	8.10	3.87	1.76	2.46	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	8.87	17.74	8.24	5.38	1.27	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.22	14.53	6.36	3.03	0.30	0.61	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	17.07	3.62	4.14	4.14	2.59	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.92	16.60	9.96	5.31	2.66	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.32	13.60	5.13	2.82	2.31	2.05	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.11	14.32	6.39	4.09	1.79	2.30	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	11.36	6.06	2.27	3.03	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.84	11.76	7.39	8.07	0.67	0.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.32	44.20	21.49	8.45	3.62	1.21	0.00	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	14.71	41.45	26.29	10.25	0.89	4.01	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.12	39.51	30.73	14.15	2.93	4.39	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.36	18.95	5.50	2.44	1.53	0.92	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	39.04	22.77	16.27	6.51	39.04	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.21	19.53	6.62	5.63	1.32	1.65	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.34	13.14	5.47	3.83	2.19	1.09	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.99	20.27	6.15	3.26	1.81	2.17	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.52	11.74	4.98	2.49	1.07	0.71	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	14.32	4.77	2.39	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	29.79	14.36	7.18	5.69	2.30	0.95	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.89	8.62	7.54	3.77	1.89	0.54	0.00	0.27
immature langerhans cells, donor1	11904-125F5	5.57	2.66	3.39	3.87	0.97	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	3.96	4.75	0.00	1.58	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	12.21	28.77	6.06	14.57	2.56	0.47	0.66	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	21.13	9.10	2.28	3.25	0.65	0.98	0.00	0.65
kidney, adult, pool1	10017-101C8	8.21	13.72	4.61	7.91	1.10	0.70	0.10	0.20
kidney, fetal, pool1	10045-101F9	6.15	11.03	4.74	7.92	0.85	0.07	0.71	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	123.27	41.47	35.36	21.02	8.66	0.71	1.28	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.96	19.91	16.73	11.20	1.52	1.94	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.77	30.09	29.73	22.39	1.47	0.73	0.73	0.18
left atrium, adult, donor1	10079-102A7	3.27	7.08	1.09	5.45	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	3.03	4.05	2.02	3.03	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.34	31.74	12.04	11.49	3.28	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	22.99	6.83	5.75	3.59	0.36	0.36	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	5.98	1.09	1.63	0.54	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	44.68	8.01	8.74	12.14	0.97	5.34	1.46	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	31.75	6.35	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	10.46	10.46	7.32	5.23	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	58.67	28.22	18.30	8.74	3.66	1.18	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	30.77	8.90	5.00	1.56	1.56	0.47	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	12.18	12.06	3.29	4.26	1.71	0.24	0.97	0.37
liver, adult, pool1	10018-101C9	12.15	16.37	21.23	14.75	0.81	0.00	0.16	0.16
liver, fetal, pool1	10086-102B5	2.82	2.82	6.58	2.82	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	11.67	21.44	5.54	9.04	1.31	0.15	0.15	0.44
locus coeruleus, adult, donor10252	10165-103B3	8.86	35.80	9.04	9.04	0.37	1.66	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	7.62	14.39	4.51	10.44	1.97	1.69	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	17.67	9.25	7.57	7.57	0.42	2.52	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	34.74	39.86	44.29	33.35	2.91	0.14	0.55	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	9.65	11.03	2.76	4.14	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	27.55	39.41	13.45	12.65	3.43	1.45	0.26	0.40
lung, adult, pool1	10019-101D1	8.62	13.35	6.85	7.21	0.59	0.12	0.12	0.00
lung, fetal, donor1	10068-101I5	4.85	14.27	8.28	7.14	0.86	0.29	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	5.96	9.62	1.83	5.04	0.00	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	5.68	16.57	6.15	3.31	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	9.64	11.62	12.49	3.95	0.66	0.44	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	71.54	38.49	13.13	10.41	4.38	0.75	0.15	4.53
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	29.73	71.36	42.47	1.70	1.70	1.70	1.70
mature adipocyte, donor1	12231-129F8	11.99	32.41	1.78	7.99	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	13.28	37.56	7.68	16.60	0.62	1.04	0.42	0.00
mature adipocyte, donor3	12233-129G1	10.43	25.60	3.56	10.43	0.95	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	7.90	23.16	4.21	6.05	1.84	0.26	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	87.20	119.84	102.45	72.19	3.81	0.71	3.10	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	5.64	12.41	0.00	6.77	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	13.06	34.76	7.17	9.20	1.29	0.74	0.37	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	4.13	16.84	2.54	8.90	0.64	1.91	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	9.81	17.91	5.97	5.97	2.13	2.99	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	10.29	21.94	4.73	8.27	0.84	7.59	0.68	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	8.91	37.56	6.37	10.82	1.06	0.42	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	11.56	0.00	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	14.35	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.90	9.33	3.95	6.10	1.44	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	5.19	9.09	6.49	9.73	1.30	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	9.60	34.68	8.82	8.67	0.93	0.31	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	11.35	25.22	8.24	13.63	1.88	0.49	0.49	0.73
medulla oblongata, newborn, donor10223	10361-105F1	12.85	14.23	4.51	9.72	0.35	1.04	0.35	2.08
medulloblastoma cell line:D283 Med	10838-111E1	7.31	50.92	64.43	50.04	1.55	4.87	6.42	0.22
medulloblastoma cell line:ONS-76	10759-110E3	21.64	14.43	5.99	4.28	1.96	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	62.96	30.76	52.75	21.42	3.88	0.29	0.43	0.29
melanoma cell line:G-361	10465-106H6	29.05	31.49	26.60	14.66	2.99	1.90	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	24.96	30.75	19.18	12.48	2.53	7.60	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	51.99	27.32	9.69	7.93	1.76	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	15.29	40.44	19.96	10.37	2.07	1.04	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	53.86	15.50	9.97	4.76	5.83	1.38	0.46	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	55.99	19.81	11.82	6.91	8.73	1.09	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.95	8.70	8.28	4.97	3.73	1.24	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.98	10.11	5.20	3.37	4.50	0.28	0.00	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.99	9.24	8.86	5.78	3.66	1.35	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	9.02	5.55	4.86	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.49	22.66	25.92	13.39	5.66	1.37	1.20	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	44.28	20.13	15.07	6.56	5.87	2.88	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.70	8.75	7.43	3.71	2.52	0.80	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.01	8.37	5.94	4.05	2.97	0.68	0.00	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	15.22	10.39	11.24	5.41	3.27	0.43	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.59	12.84	26.35	15.81	2.96	0.66	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.66	12.04	9.41	6.50	4.84	0.55	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.99	10.12	8.03	5.59	2.44	1.40	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.05	8.17	8.57	3.06	2.45	1.84	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	18.33	8.99	14.02	10.42	2.88	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.21	7.45	4.76	2.79	1.34	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	3.42	4.79	3.42	0.68	0.91	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.20	5.87	5.45	6.29	2.52	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.45	8.97	8.67	5.83	2.99	1.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.41	14.00	15.76	7.62	3.76	1.75	0.35	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.93	18.41	23.56	12.89	3.31	0.74	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.03	8.30	10.87	7.44	1.43	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	22.31	6.74	2.53	0.84	1.26	1.26	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	43.38	14.16	7.31	10.05	4.57	0.91	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	48.60	16.11	11.00	7.93	3.58	1.28	0.77	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	56.80	18.58	7.59	8.38	4.45	1.83	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	47.45	16.33	9.86	8.32	3.39	3.70	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	52.01	15.53	6.83	7.53	4.71	2.35	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.71	12.52	11.51	8.80	3.38	1.02	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	52.27	12.97	12.58	7.07	3.93	3.14	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	45.88	11.12	8.80	6.49	2.32	4.17	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	55.95	19.04	10.38	9.52	4.90	3.46	0.00	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	50.42	15.62	7.14	10.93	5.35	2.01	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	55.28	18.99	9.85	6.73	4.57	1.68	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	76.27	19.80	16.87	11.73	6.60	3.67	0.00	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.61	11.08	6.38	7.05	4.36	1.34	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	47.90	13.92	7.78	7.37	2.87	1.64	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.08	9.45	10.31	5.15	2.58	1.72	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	62.89	8.20	0.00	10.94	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	10.33	10.33	20.66	10.33	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.07	17.21	8.44	4.55	5.85	2.60	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	36.37	10.18	16.00	2.91	5.82	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	61.30	20.26	12.79	10.13	4.26	2.67	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	49.88	22.08	11.45	6.54	4.09	2.45	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	37.71	16.33	8.16	6.22	2.72	2.33	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	14.69	10.49	8.39	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	9.93	8.94	5.96	2.98	3.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	0.00	9.53	0.00	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	50.99	18.38	14.82	7.12	2.37	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	10.97	7.31	4.87	6.09	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.20	13.93	7.60	5.70	3.17	3.17	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	42.77	17.59	9.66	9.31	6.90	2.76	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	21.49	6.45	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	15.97	11.98	11.98	3.99	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	13.78	17.22	6.89	3.44	17.22	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.41	15.08	9.78	4.07	4.07	2.04	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	16.68	7.94	6.36	1.59	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.33	14.15	10.02	5.31	1.77	4.72	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.14	14.65	6.86	7.48	1.56	1.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	16.04	6.68	4.01	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	7.10	5.91	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	12.84	5.14	5.14	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	7.57	11.70	4.13	2.75	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	9.90	8.41	5.94	0.49	0.49	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	17.94	4.49	2.24	0.00	4.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	8.90	15.27	4.45	0.00	3.82	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.64	11.28	10.88	8.46	1.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	8.72	10.90	8.72	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	7.60	5.07	8.87	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	25.49	23.67	33.99	22.45	3.64	1.21	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	18.08	58.75	54.23	0.00	13.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.12	27.18	52.72	24.71	4.12	7.41	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.01	21.83	12.50	8.33	1.59	0.60	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.66	13.63	9.09	12.66	3.24	2.60	0.32	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	15.28	13.24	11.20	3.06	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.01	21.66	12.38	7.74	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	8.74	27.17	39.45	31.42	2.13	0.00	1.65	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	25.25	10.43	11.35	16.45	1.62	0.00	2.32	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	17.09	8.55	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	79.73	13.67	15.41	5.65	3.19	5.24	0.21	0.72
mesothelioma cell line:Mero-25	10850-111F4	42.89	15.66	25.19	19.74	4.77	2.27	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	62.10	16.87	10.02	8.31	4.89	3.67	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	14.17	9.52	5.98	3.99	1.11	0.66	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	74.90	21.55	28.12	11.83	4.99	9.99	0.53	0.79
mesothelioma cell line:Mero-83	10854-111F8	23.32	10.89	8.68	5.62	2.38	1.19	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	8.85	5.31	24.27	15.67	0.25	1.26	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	31.88	15.94	10.56	7.04	3.11	0.83	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	32.47	9.61	4.80	3.48	3.48	0.99	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	39.28	13.57	19.55	15.20	3.08	1.45	0.36	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	50.91	13.84	7.17	5.12	2.90	0.68	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	18.32	9.42	6.36	7.89	3.56	0.76	0.25	0.51
mesothelioma cell line:No36	10857-111G2	20.22	22.51	22.51	14.68	2.94	1.96	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	39.56	12.73	12.19	11.11	1.90	1.90	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	2.11	3.45	4.41	3.84	0.19	0.38	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	2.44	6.96	3.66	1.71	0.12	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	2.87	4.85	1.62	3.41	0.36	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.26	39.50	96.64	36.24	2.61	17.96	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.50	21.62	14.41	8.69	2.33	2.12	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	31.79	55.98	40.08	28.10	3.69	0.46	1.15	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.47	9.32	4.76	2.28	0.76	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.65	37.70	29.38	15.15	3.70	0.18	0.00	0.18
myeloma cell line:PCM6	10474-106I6	45.86	31.82	42.70	71.36	3.16	1.58	1.78	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.92	17.76	10.15	7.10	4.06	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	42.95	13.14	6.08	3.33	4.71	1.18	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.05	44.68	25.52	15.60	0.89	0.78	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	16.03	40.96	29.78	15.08	2.13	0.51	0.74	0.00
nasal epithelial cells, donor2	12227-129F4	24.84	25.39	18.22	11.04	2.21	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	23.93	100.77	84.89	51.07	3.91	0.46	1.61	0.00
neuroblastoma cell line:NB-1	10539-107G8	34.05	37.23	29.93	17.21	4.12	0.19	0.00	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	38.59	106.08	126.53	51.88	1.48	6.12	2.53	0.63
neuroblastoma cell line:NH-12	10555-107I6	20.31	53.86	35.41	14.91	2.98	0.37	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.12	34.87	19.93	7.12	1.19	2.61	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.32	77.29	47.99	27.24	3.17	4.75	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	24.55	33.21	27.98	14.09	2.01	1.21	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	64.21	48.32	12.72	1.91	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	63.08	27.42	20.23	17.30	6.12	0.27	1.86	0.53
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	70.35	77.46	64.43	28.07	3.21	0.85	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	28.02	8.81	5.60	0.80	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.15	28.53	21.48	16.03	5.45	1.92	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.22	14.71	12.09	7.36	1.84	1.31	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	11.90	27.65	5.62	12.28	1.97	0.56	0.28	0.75
occipital cortex - adult, donor10196	10172-103C1	8.24	16.48	4.12	8.24	0.00	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	11.54	38.91	6.98	10.73	1.07	1.07	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	13.47	14.92	8.37	3.64	1.46	0.36	0.00	1.82
occipital lobe, adult, donor1	10076-102A4	9.18	23.35	4.72	13.64	1.57	0.26	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	4.29	23.60	6.44	5.58	1.72	1.29	0.00	0.86
occipital pole, adult, pool1	10036-101E9	7.81	20.18	3.63	9.86	0.87	0.08	0.16	0.55
olfactory region, adult	10195-103E6	4.01	21.59	4.01	7.26	1.15	0.19	0.19	0.38
optic nerve, donor1	10277-104E7	10.01	16.01	8.00	18.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	32.92	39.64	52.28	35.54	4.33	0.80	0.34	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.66	31.32	21.57	35.17	0.69	0.69	4.95	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.18	26.41	20.49	14.39	2.54	5.25	0.17	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	39.85	30.38	31.30	13.28	6.12	2.19	0.35	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	69.38	20.87	17.64	19.11	4.70	1.18	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	112.12	56.99	29.90	15.88	5.61	0.00	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	26.51	29.90	61.29	33.51	2.33	0.85	1.48	0.21
ovary, adult, pool1	10020-101D2	8.47	15.29	5.94	9.00	0.96	0.17	0.26	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	44.73	21.27	9.72	7.15	5.13	0.92	0.55	0.55
pancreas, adult, donor1	10049-101G4	21.63	12.23	9.41	14.11	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	45.56	85.26	76.31	36.34	5.31	1.40	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	48.38	17.89	22.15	8.18	3.24	4.43	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	27.98	18.21	12.92	10.27	1.16	0.33	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	9.79	26.45	6.32	10.43	1.28	0.37	0.46	0.55
parietal cortex, adult, donor10258	10373-105G4	1.47	14.68	3.67	2.94	0.00	0.73	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	3.76	14.11	1.88	6.58	2.82	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	8.55	26.51	6.56	7.70	1.43	1.71	0.00	0.86
parietal lobe, adult, pool1	10034-101E7	10.13	25.47	5.02	13.66	1.06	0.00	0.44	0.70
parietal lobe, fetal, donor1	10072-101I9	5.82	31.03	4.85	4.85	2.91	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	13.83	14.58	9.35	4.11	1.12	0.75	0.00	0.75
parotid gland, adult	10199-103F1	16.65	27.75	6.17	12.33	0.62	0.62	0.00	0.62
penis, adult	10200-103F2	7.52	6.45	0.54	3.22	1.07	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.87	60.80	24.92	22.31	1.67	1.67	1.67	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	32.05	38.90	44.73	35.55	2.91	1.46	0.73	0.73
pineal gland - adult, donor10196	10179-103C8	3.23	14.84	3.87	5.81	0.00	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	11.84	36.12	4.15	5.33	0.00	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	6.90	21.95	2.51	3.76	0.63	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	10.12	12.14	4.05	12.14	1.01	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	13.03	47.43	11.47	16.68	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	5.96	23.83	5.11	11.92	1.70	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	5.59	12.36	7.42	6.02	0.22	0.22	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	6.89	25.69	28.60	16.16	0.93	1.06	0.13	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.06	12.92	7.78	13.54	1.40	0.16	0.16	0.16
pons, adult, pool1	10033-101E6	14.46	26.42	5.08	13.08	1.03	0.52	0.77	0.43
postcentral gyrus, adult, pool1	10032-101E5	7.76	24.15	4.88	11.68	1.83	0.52	0.09	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	123.39	25.10	6.27	2.09	2.09	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	11.02	11.02	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	18.35	35.83	19.52	17.04	2.33	1.31	0.15	0.29
prostate cancer cell line:PC-3	10439-106E7	49.19	31.94	20.87	10.71	5.08	0.18	0.00	0.54
prostate, adult, pool1	10022-101D4	5.35	12.42	2.81	4.17	1.09	0.09	0.27	0.00
putamen, adult, donor10196	10176-103C5	11.33	34.47	3.54	9.44	1.89	0.71	0.71	0.24
putamen, adult, donor10252	10152-102I8	17.65	35.29	5.88	9.80	3.92	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	19.67	13.11	2.19	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	9.66	20.05	3.62	7.25	0.48	1.21	0.00	0.00
putamen, newborn, donor10223	10365-105F5	4.50	8.25	6.00	0.75	0.75	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	24.73	52.37	51.20	32.88	3.49	0.00	0.29	0.58
rectum, fetal, donor1	10067-101I4	13.91	15.30	2.78	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	26.50	14.20	3.60	2.76	1.27	0.42	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.77	25.68	10.77	19.05	2.07	2.49	0.41	0.00
retina, adult, pool1	10030-101E3	8.65	20.18	8.45	9.64	1.59	0.10	0.00	0.30
retinoblastoma cell line:Y79	10475-106I7	20.52	42.61	18.19	10.39	4.16	0.78	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.94	28.16	12.29	15.00	1.35	0.49	0.37	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	50.33	123.45	135.26	70.02	3.94	0.56	2.25	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.07	19.70	9.09	6.82	4.55	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	17.16	11.82	6.15	5.83	2.10	0.97	0.16	0.32
salivary acinar cells, donor2	11772-123I8	5.92	7.99	3.17	3.44	0.28	0.55	0.28	0.00
salivary acinar cells, donor3	11773-123I9	7.28	12.58	8.61	3.97	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	5.72	9.72	3.43	5.15	1.14	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	95.44	53.79	32.63	18.55	10.88	0.84	0.42	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	97.80	54.43	29.98	19.16	10.93	1.41	0.47	0.35
seminal vesicle, adult	10201-103F3	5.82	15.34	2.65	5.82	0.53	3.17	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	24.05	12.88	9.72	7.04	1.46	2.43	0.00	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	10.32	9.56	4.53	1.51	1.76	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	16.06	8.03	3.01	3.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	44.33	44.46	32.91	20.95	2.82	2.69	0.81	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	68.97	29.07	38.13	25.20	1.88	0.44	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	25.81	11.48	6.06	2.19	2.06	0.13	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	0.00	4.26	2.13	2.13	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	4.32	6.36	1.32	3.36	0.24	0.00	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	9.05	8.04	3.02	3.02	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	11.99	22.09	2.52	13.89	0.63	1.89	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	21.01	37.69	25.68	16.68	2.33	1.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.61	46.34	23.96	11.35	4.10	1.58	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	5.40	46.26	27.18	20.82	5.20	2.12	0.39	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	93.29	66.43	64.94	25.38	4.78	0.99	0.66	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.93	32.49	37.96	23.32	0.64	1.61	0.97	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	79.76	69.30	36.39	32.03	5.45	1.74	0.44	0.44
small intestine, adult, pool1	10024-101D6	6.69	10.15	2.75	3.58	0.60	0.12	0.12	0.12
small intestine, fetal, donor1	10064-101I1	4.18	9.58	1.72	2.70	0.25	1.23	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.93	22.05	13.34	11.28	2.56	5.13	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	6.20	15.51	1.03	6.20	0.78	0.52	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	52.26	84.16	70.49	33.23	5.36	0.54	1.07	0.54
spinal cord - adult, donor10196	10181-103D1	9.64	18.35	3.44	8.95	0.46	2.75	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	12.62	37.46	9.46	11.83	1.97	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	2.77	12.45	6.92	4.84	0.69	2.77	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	9.15	28.66	7.32	7.32	1.22	1.83	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	21.58	14.24	7.81	8.27	3.67	1.38	0.46	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	94.69	26.29	16.13	13.74	6.42	1.19	0.00	0.75
spleen, adult, pool1	10025-101D7	7.05	12.11	8.37	5.07	0.88	0.22	0.00	0.11
spleen, fetal, pool1	10044-101F8	11.76	11.28	8.58	4.85	1.27	0.00	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.42	13.66	9.32	8.18	1.14	0.41	0.00	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	17.85	40.63	18.99	15.19	1.90	0.38	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.82	67.44	52.77	35.99	2.10	10.13	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.10	47.69	64.89	24.24	4.30	3.13	2.35	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	29.15	25.66	24.09	17.78	2.25	0.56	0.45	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	15.67	42.78	28.38	19.06	1.69	2.12	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.92	31.31	22.42	9.31	4.65	0.42	0.00	0.85
stomach, fetal, donor1	10062-101H8	10.68	8.54	0.00	5.34	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	10.82	21.08	5.13	8.55	1.14	0.57	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.35	36.76	9.14	8.72	1.45	1.25	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	2.07	15.52	6.21	8.28	0.00	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	10.60	13.42	6.36	6.36	0.00	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	34.62	55.94	29.35	13.07	5.50	0.92	0.00	1.15
temporal lobe, adult, pool1	10031-101E4	6.70	18.56	3.65	8.82	1.36	0.25	0.08	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.27	24.93	3.56	4.99	1.42	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	2.64	20.66	2.64	7.03	0.00	0.88	0.00	0.44
tenocyte, donor1	11763-123H8	31.42	11.52	6.28	5.59	2.79	3.49	0.35	0.00
tenocyte, donor2	11765-123I1	8.39	9.16	1.53	5.72	1.91	1.53	0.38	0.00
tenocyte, donor3	11768-123I4	13.34	7.78	2.97	6.30	1.11	2.22	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	19.38	38.24	26.00	9.86	3.74	1.02	0.68	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	11.72	19.27	13.26	7.09	1.70	0.92	0.31	0.92
teratocarcinoma cell line:PA-1	10807-111A6	19.84	44.79	27.43	11.16	2.48	1.39	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.63	59.67	98.51	71.60	2.67	0.89	2.79	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	25.72	107.40	108.54	39.71	2.65	1.89	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	57.15	95.43	105.14	35.45	7.20	2.51	0.87	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.24	45.60	48.53	24.43	3.26	7.82	0.00	0.65
testis, adult, pool1	10026-101D8	5.69	16.86	6.87	8.91	2.36	0.54	0.43	0.64
testis, adult, pool2	10096-102C6	4.06	32.93	8.12	16.24	4.06	2.71	1.35	0.90
thalamus - adult, donor10196	10168-103B6	14.35	18.77	5.52	5.52	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	11.25	35.63	7.03	12.03	1.09	0.47	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	7.70	7.70	18.48	1.54	3.08	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.72	12.19	4.28	6.75	1.15	0.99	0.49	0.16
thalamus, newborn, donor10223	10366-105F6	8.63	11.51	4.60	5.18	0.00	1.73	0.58	0.58
throat, adult	10209-103G2	7.99	10.24	3.00	4.24	0.75	0.25	0.00	0.00
throat, fetal, donor1	10061-101H7	9.75	17.98	4.57	11.27	2.44	0.61	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	19.08	75.32	21.26	14.31	4.57	1.39	0.40	0.40
thymus, adult, pool1	10027-101D9	11.53	17.60	7.95	7.16	1.49	0.50	0.20	0.60
thymus, fetal, pool1	10043-101F7	9.25	18.50	7.38	6.96	1.04	0.31	0.21	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	38.82	20.21	16.75	9.84	4.65	0.93	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	46.52	31.29	22.21	17.32	4.05	0.98	0.70	0.42
thyroid, adult, pool1	10028-101E1	14.46	28.74	12.60	16.52	0.65	0.37	0.47	0.28
thyroid, fetal, donor1	10060-101H6	7.65	19.51	4.75	10.02	0.26	2.64	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	6.16	6.16	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	12.33	7.68	2.33	5.35	0.70	1.63	0.00	0.23
tongue, fetal, donor1	10059-101H5	9.46	14.98	4.34	5.12	0.79	0.39	0.00	0.39
tonsil, adult, pool1	10047-101G2	14.53	14.33	6.41	6.31	1.30	0.10	0.00	0.30
trachea, adult, pool1	10029-101E2	13.99	17.18	6.13	5.15	1.06	0.16	0.08	0.16
trachea, fetal, donor1	10058-101H4	10.77	16.16	2.31	4.23	0.38	0.00	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	33.30	16.65	8.15	8.15	4.25	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	57.24	15.10	8.11	3.75	4.05	0.10	0.10	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.94	46.22	41.99	28.67	3.76	0.78	1.25	0.16
tridermal teratoma cell line:HGRT	10694-109G1	20.93	5.71	5.71	9.51	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	38.18	34.79	41.31	35.21	2.54	1.27	1.44	0.08
umbilical cord, fetal, donor1	10057-101H3	10.43	16.69	12.52	8.35	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	5.12	10.58	3.24	5.97	1.02	0.00	0.34	0.17
uterus, fetal, donor1	10055-101H1	13.82	15.36	4.10	6.66	1.54	0.51	0.00	0.00
vagina, adult	10204-103F6	9.69	15.51	9.69	22.62	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	5.70	10.74	3.51	4.82	0.22	0.22	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.27	13.62	4.81	2.14	1.07	0.53	0.00	0.00